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Δει διαλαβειν óτι και ο πολυς λóγος  
και ο βραχυς εις τò αυτò συντεινει. Epikur, Sprüche 26. 
Summary  The nucleolus is the most prominent subnuclear compartment in eukaryotic cells. It  has  a  central  function  in  the  biogenesis  of  ribosomal  subunits,  but  the  past decade has revealed that a variety of additional non‐ribosomal ribonucleoprotein (RNP)  complexes  require passage  through  the nucleolus during  their maturation as  well.  Examples  include  small  nuclear  RNPs  (snRNPs),  the  signal  recognition particle  (SRP),  and  viral  RNPs.  Recent  data  show  that  also  specific  localized messenger RNAs (mRNAs) or proteins implicated in their localization either reside predominantly in the nucleolus or accumulate there under certain conditions. This  study presents  evidence  that  two mainly nucleolar RNA‐binding proteins of the  yeast  Saccharomyces  cerevisiae,  Loc1  and  Puf6,  influence  the  localization  of 






1.1. The nucleolus The nucleus is one of the largest organelles in eukaryotic cells. It is surrounded by a double membrane and its interior is highly organized into a variety of subnuclear domains  of  specialized  functions,  such  as  Cajal  bodies,  promyelolytic  leukemia oncoprotein  (PML)  bodies,  nuclear  speckles,  and, most  prominent,  the  nucleolus (Handwerger  &  Gall,  2006).  A  membrane  does  not  surround  any  of  the intranuclear  domains  and  organelles,  which  rather  form  by  self‐organization (Misteli, 2001), yielding steady‐state structures composed of dynamic components without a rigid architectural framework (Colau et al., 2004). The nucleolus has been discovered by  the  Italian natural scientist Felice Fontana (Fontana, 1781;  for a brief historical overview of  science  involving  the nucleolus see Maggi & Weber, 2005). Electron microscopy (EM) studies have been the basis for the definition of three structural subcompartments, referred to as the fibrillar centers (FC), the dense fibrillar compartment (DFC), and the granular component (GC) (Figure 1).   
     
Figure 1 Nuclear ultrastructure 













This  traditional  view  has  been  challenged  with  the  suggestion  that  tripartite nucleoli are only present  in amniote vertebrates, whereas most other eukaryotes contain  only  bipartite  nucleoli,  composed  of  fibrillar  strands  (F)  embedded  in granules (G) (Thiry & Lafontaine, 2005). However, this hypothesis requires a very strict definition of FCs. A broader definition based on ultrastructural comparative morphology  upholds  the  original  allocation  I  will  use  throughout  this  thesis (Trumtel  et  al.,  2000,  Isabelle  Léger‐Silvestre,  personal  communication).  At  any rate,  proportions  and  arrangement  of  nucleolar  components  are  not  static,  but vary depending on  environmental  conditions,  cell  type  and  species  (Raška  et  al., 2006).  In  contrast  to  higher  eukaryotes,  the  budding  yeast  Saccharomyces  cerevisiae (simply  referred  to  as  yeast  in  this  study),  a  unicellular  eukaryotic  model organism, contains only one nucleolus, which assembles around the rDNA repeats of  chromosome  XII  (Johnston  et  al.,  1997).  It  has  the  shape  of  a  crescent  and occupies  about  one  third  of  the  nucleus  (Figure  1;  Carmo‐Fonseca  et  al.,  2000). Yeast  undergoes  closed mitosis,  and  the  nucleolus  is  separated  very  late  during mitosis,  regulated  by  the  FEAR  (for  Cdc14  early  anaphase  release)  network (D'Amours et al., 2004; Torres‐Rosell et al., 2004). 




Figure 2   Ribosome biogenesis in Saccharomyces cerevisiae. A   Structural  organization  of  yeast  ribosomal DNA  (rDNA)  repeats.  Each  9.1  kb  rDNA  repeat  is organized  into  a  Pol  I  transcription  unit  (35S),  and  a  nontranscribed  spacer  (NTS).  The  NTS contains two cis‐acting elements, a replication fork barrier (RFB), and an autonomously replicating sequence (rARS). A 5S rRNA Pol  III  transcription unit (5S)  is  located between rARS and RFB. The transcript of the 35S rDNA contains the 18S, 5.8S, and 25S rRNAs separated by spacer sequences – two  external  transcribed  spacers  (ETS)  and  two  internal  transcribed  spacers  (ITS),  respectively. Cleavage  and  processing  sites  are  indicated  (see  below  for  details).  (Figure  adapted  from Burkhalter & Sogo, 2004; Fromont‐Racine et al., 2003). B   Processing  of  pre‐rRNAs  and  assembly  of  ribosomes.  Following  initial  cleavages  at  different sites of the primary transcript  in the 90S pre‐ribosome, cleavage at site A2 separates pre‐40S and pre‐60S particles. While small subunit precursors are exported to the cytoplasm relatively fast, pre‐rRNAs  of  the  large  subunit  precursors  are  subjected  to  extensive  cleavage  and  processing.  The great majority of pre‐60S rRNAs are processed starting with cleavage of 27SA2 rRNA at site A3, but a  substantial  part  is  alternatively  processed  directly  at  site  B1L.  (Figure  adapted  from  Fromont‐Racine  et  al.,  2003;  Henras  et  al.,  2008).  Abbreviations:  cl  –  cleavage;  pr  –  processing;  ex  – exonuclease processing.  18S rRNA, RNA polymerase II (Pol II) transcribes the ribosomal protein genes, and RNA  polymerase  III  (Pol  III)  provides  5S  rRNA  (for  review,  see  Cramer  et  al., 2008).  This  coordinated  action  of  all  three  eukaryotic  transcription machineries 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accounts  for  approximately  80%  of  nuclear  transcription  in  yeast  (Moss  & Stefanovsky, 2002). Ribosome biogenesis has been studied in great detail in S. cerevisiae over the past 40 years  (for  a  recent  review,  see Henras et  al.,  2008). A  substantial part of  this process  takes  place  inside  the  nucleolus,  whose  ultrastructural  organization  is thought  to  reflect  the  vectorial  nature  of  ribosome  biogenesis  –  pre‐ribosomes move from the fibrillar to the granular parts and then out of the nucleolus to the nucleoplasm (Thiry & Lafontaine, 2005).  The rRNAs are encoded by ribosomal DNA (rDNA), which is organized in 100 – 200 9.1  kb  repeats  on  the  long  arm  of  chromosome  XII  (Figure  2A;  Johnston  et  al., 1997).  Transcription  by  Pol  I  and  co‐transcriptional  recruitment  of  a  variety  of factors, including the U3 snoRNP, ribosomal proteins and mostly pre‐40S ribosome biogenesis  factors  to  the  primary  transcript  yields  the  first  detectable  ribosome precursor, termed the 90S pre‐ribosome (Figure 2B; Dragon et al., 2002; Grandi et al., 2002). Cleavage at site A2 leads to formation of pre‐40S and pre‐60S particles. While  the  pre‐40S  subunit  is  associated  with  only  eight  major  non‐ribosomal proteins  and  exported  to  the  cytoplasm  relatively  fast  (Schäfer  et  al.,  2003), elaborate  processing  of  rRNA  precursors  accompanied  by  rearrangements  in protein  composition  is  required  for  pre‐60S  subunit  maturation  (Figure  2B; Harnpicharnchai et al., 2001; Nissan et al., 2002; Saveanu et al., 2003); notably, the number of associated non‐ribosomal  factors decreases  from early to  late pre‐60S particles  (Nissan  et  al.,  2002).  The  intermediate  27SA2  pre‐rRNA  can  be  further processed following two mutually exclusive paths, finally resulting in two different populations of ribosomes containing a short (S) and a long (L) form of 5.8S rRNA (Henras et al., 2008).  Besides  exo‐  and  endonucleolytic  cleavage  steps,  nucleolar  processing  of  rRNAs also  involves  post‐transcriptional  modification  of  nucleotides  such  as pseudouridylation and 2´‐O‐ribose methylation (Figure 29A; Reichow et al., 2007). A set of guide snoRNAs target specific nucleotides by direct base pairing. The C/D class of snoRNPs carries out methylation, whereas H/ACA class snoRNPs convert uridine  to  pseudouridine  (for  review  see  Matera  et  al.,  2007).  Interestingly, snoRNPs  modify  not  only  rRNAs  and  snRNAs,  but  probably  also  other  cellular RNAs  including  mRNAs  (Gerbi  et  al.,  2003;  Kiss,  2002).  Export‐competent  pre‐ribosomal  particles  are  transported  to  the  cytoplasm,  where  final  maturation 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occurs.  Nuclear  export  involves  a  Ran  GTPase  cycle  and  a  specific  subset  of nucleoporins  (Henras et al., 2008).  In  total,  the astounding number of about 200 non‐ribosomal proteins is implicated in ribosome biogenesis. 
1.3. Localization of mRNAs Polarity is a characteristic trait common to nearly all kinds of cells. One important mechanism cells apply to establish polarity is the localization of messenger RNAs coupled  to  local  translation.  Recent  studies  suggest  that  mRNA  localization  in eukaryotic  cells  is  much  more  prevalent  than  anticipated  and  serves  a  large number of biological functions (see for example Lécuyer et al., 2007). Localization of  mRNAs  has  several  advantages  over  localization  of  proteins.  Besides  spatial restriction of gene expression that can be easily regulated over time,  targeting of mRNAs is economic because it allows production of multiple protein molecules at the target site with active transport of  just one mRNA molecule. Finally, proteins may  have  properties  undesirable  at  sites  other  than  the  destination  (Martin  & Ephrussi, 2009).  Localized mRNAs  are probably best  known  for  their  role during development  in metazoans, with Drosophila and Xenopus oocytes as the classic model systems. For example,  Vg1  mRNA  encodes  a  TGF‐β  (for  transforming  growth  factor)  family protein that functions in mesoderm induction and is targeted to the vegetal pole of 




Figure 3   Examples of localized mRNAs. RNA‐binding proteins (blue) and mRNAs (red) form localizing RNPs that travel along cytoskeletal filaments  to  their  respective  destination.  Correct  localization  of  all  example  mRNPs  presented depends on their nuclear history (see section 1.5). A  Vg1 is a late pathway mRNA that localizes to the vegetal pole of Xenopus laevis oocytes at later stages of their development. The RNP is transported along microtubules B   In Drosophila melanogaster, oskar mRNA  is  transported  along microtubules  to  the  posterior pole of oocytes. C    β­actin  mRNA  is  targeted  to  the  leading  edge  of  lamellipodia  in  chicken  and  mammalian fibroblasts utilizing actin/myosin dependent transport. D  mRNPs  containing ASH1 mRNA  travel  along actin  filaments  to  the  tip of  the daughter  cell  in 
Saccharomyces cerevisiae. Figure based on Martin & Ephrussi, 2009. 
1.4. A simple model system: mRNA localization in yeast 










































WSC2  S  membranes, bud  The most substantial part of the knowledge on mRNA localization in yeast derives from studies on ASH1, which encodes a transcriptional repressor (see below) and is probably the best‐characterized targeted mRNA.  Four  structured  cis‐acting  sequences,  termed  localization  elements  (LEs)  or  zip codes, participate in targeting of ASH1 mRNA. While the E3 LE lies mostly in the 3´‐
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untranslated  region  (UTR)  of  the ASH1  ORF,  the  elements  E1,  E2A,  and  E2B  are entirely  located  in  the coding region (Figure 4A; Chartrand et al., 1999). Each LE alone is sufficient for localization, but they need to cooperate to anchor ASH1 at the target site (Jansen, 2001). In contrast to metazoans, localization elements that map to the coding sequence seem to be a general theme in yeast (Shepard et al., 2003); 
IST2  mRNA  contains  one  LE  near  the  3´‐end  of  the  ORF  (nt  2694‐2785), WSC2 mRNA one in the 5´‐part (nt 418‐471) and one in the 3´‐part (nt 1313‐1384) of the ORF  (Jambhekar  et  al.,  2005;  Olivier  et  al.,  2005).  The  localization  elements  are predicted  to  fold  into  hairpin  stem  loops  as  represented  schematically  in  Figure 4A;  recognition  of  an  LE  by  RNA‐binding  proteins  depends  on  precise  three‐dimensional  structures as well  as  secondary structure and certain nucleotides  in the primary sequence (Jambhekar & DeRisi, 2007). 
1.4.2. trans‐acting factors Interestingly, a small  set of proteins,  comprising She proteins and  few additional factors,  seems  to  be  sufficient  to  transport  all  localized  transcripts,  despite  their large  number.  Five  SHE  (for  Swi5‐dependent  HO  expression)  genes  have  been identified in a screen for mother cell‐specific activators of HO expression (Jansen et al.,  1996). HO  encodes  an  endonuclease  that  allows  haploid  S.  cerevisiae  cells  to switch between the two mating types a and α; however, it is only expressed in cells that have previously budded (so‐called mother cells). In daughter cells (i.e. former buds that have not yet budded themselves), HO transcription is repressed by Ash1, whose corresponding mRNA is localized to the bud tip during cell division (Bobola et al., 1996; Long et al., 1997). Three  of  the  five  She  proteins  participate  directly  in  transport  of  ASH1  and  all other  localized  mRNAs  characterized  so  far  (Figure  4B).  She2  is  the  key  RNA‐binding protein; it binds directly to all four ASH1 LEs as well as to the LEs of other localized  mRNAs  (Figure  4;  Böhl  et  al.,  2000;  Shepard  et  al.,  2003).  Structure determination of a truncated version of She2 by X‐ray crystallography identified a particular  RNA‐binding  motif  termed  basic  helical  hairpin,  and  additional experiments  suggested  that  dimerization  is  indispensable  for  correct  function (Niessing et al., 2004). The motor protein responsible  for  the  transport of  localized mRNPs  towards  the barbed  end  of  actin  filaments  at  the  bud  tip  is  a  class  V  myosin,  Myo4  (She1; 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Haarer et al., 1994;  Jansen et al., 1996;  for review, see Sellers, 2000). Myo4 does not  interact  directly  with  She2‐mRNA  complexes;  instead,  it  binds  with  its  C‐terminal  tail  and  a  coiled‐coil  region  to  the  N‐terminal  domain  of  an  adapter protein,  She3  (Heuck  et  al.,  2007).  The  C‐terminal  domain  of  She3,  in  turn, interacts with She2 (Böhl et al., 2000).  
 
Figure 4   cis-acting elements and trans-acting factors involved in ASH1 mRNA 
localization. A  ASH1 mRNA contains four localization elements (LE), E1, E2A, E2B, and E3 (numbers indicate nucleotides  relative  to  start  of  coding  sequence).  The  first  three  LE  lie within  the  coding  region, indicated by the black line between the Start (green rectangle) and the Stop (red rectangle) codon of the ASH1 ORF, whereas most of the 118 nt E3 LE is located in the 3´‐UTR. She2 binds to all four LE. Loc1 has been shown to bind to E1 and E3, while Khd1 and Puf6 bind to a single LE, E1 and E3, respectively. B  Core transport components of mRNA localization in yeast. She2 binds directly to the respective mRNA. She3 serves as an adaptor between the RNA‐binding protein and the motor protein, Myo4, which transports the mRNP along actin filaments to the bud.  Apart  from  the  She  proteins,  additional  factors  are  required  to  ensure  correct localization  of mRNAs  (Figure  4B),  at  least  for ASH1 mRNA, which  is  the model mRNA where the major part of data available so far stems from. Khd1 (for hnRNP K homology‐domain protein), a protein shuttling between nucleus and cytoplasm, binds to the E1 LE and represses translation of ASH1 mRNA during transport (Irie et  al.,  2002).  Translational  silencing  is  accomplished  through  interaction  with Tif4631,  the  yeast  homolog  of  eukaryotic  translation  initiation  factor  eIF4G1.  At the  target  site,  Yck1  (for  yeast  casein  kinase)  phosphorylates  Khd1,  releases  it from the mRNA and thus activates translation (Paquin et al., 2007). A  second  translational  repressor  of  ASH1  mRNA  is  Puf6,  a  member  of  the  PUF protein  family,  named  after Drosophila melanogaster  Pumilio  and Caenorhabditis 

















through  an  RNA‐dependent  interaction with  the  yeast  homolog  of  eIF5B,  Fun12 (for  function  unknown  now;  Coleman  et  al.,  1986;  Deng  et  al.,  2008).  The translational block is lifted via phosphorylation of Puf6 by the casein kinase CK2. The exact function of another trans‐acting factor, Loc1 (for localization of mRNA), is as yet unclear. Loc1 is exclusively nuclear, binds to two ASH1 zip codes, E1 and E3,  and  cells  where  the  LOC1  gene  is  deleted  show  dramatic  mislocalization  of 
ASH1  mRNA  (Long  et  al.,  2001).  Another  study  proposed  a  role  for  Loc1  in translational  regulation  (Komili  et  al.,  2007).  In addition,  there  is data  indicating that Loc1 does not only function in mRNA localization, but also in the biogenesis of ribosomes (Harnpicharnchai et al., 2001; Urbinati et al., 2006). 
1.5. The nuclear history of mRNA localization Localization of all RNAs necessarily starts in the nucleus, since this is the cellular compartment where transcription takes place. However,  it has become clear  that the  role  of  the  nucleus  extends  much  further.  A  variety  of  nuclear  or  nuclear‐cytoplasmic  shuttling  proteins  are  indispensable  for  the  formation,  translational regulation  and  correct  localization  of mRNPs  (Figure  5;  for  review,  see Giorgi & Moore, 2007). Taking  the  mRNAs  from  Figure  3  as  examples,  the  proteins  Vg1RBP/vera  and hnRNP I  form a core RNP with Vg1 mRNA before  the complex  is exported  to  the cytoplasm, where  it  is remodeled and transported to the vegetal cortex (Kress et al.,  2004).  In  fibroblasts,  the  predominantly  nuclear  protein  ZBP2  associates  co‐transcriptionally with β­actin mRNA to alleviate recruiting of ZBP1, a mammalian ortholog  of  Vg1RBP  that  influences  localization  and  translational  regulation (Hüttelmaier  et  al.,  2005;  Pan  et  al.,  2007).  Targeting  of  oskar  mRNA  to  the posterior pole of Drosophila  oocytes depends on  interaction with proteins of  the exon  junction  complex  (EJC)  in  the  nucleus  (Hachet  &  Ephrussi,  2004).  Finally, 




Figure 5   Nucleo-cytoplasmic 
shuttling proteins participate 
in localization of mRNPs. RNA‐binding  proteins  (RNA‐BPs) required  for  transport  (blue) and/or  translational  regulation (red)  associate  with  the  primary transcript  (black).  Export‐competent  mRNPs  leave  the nucleus (nu) through nuclear pore complexes  (NPCs,  yellow). Subsequently,  they  are transported  along  the cytoskeleton  with  the  help  of motor  proteins  (orange)  to  their destination  at  the  cell  periphery. After  anchoring,  the  proteins bound  to  the  transcript  are released,  the mRNA  is  translated, and  the  RNA‐BPs  shuttle  back  to the nucleus. (Figure adapted from Farina & Singer, 2002). 


















2.1. The yeast‐specific protein Loc1 localizes mainly to the nucleolus The protein Loc1 (for localization of mRNA) has first been described in a study that aimed  at  identification  and  characterization  of  factors  involved  in  ASH1  mRNA localization  in  addition  to  the  She  proteins  (Long  et  al.,  2001).  In  this  study, immunofluorescence demonstrated that Loc1 localizes only to the nucleus (Long et al.,  2001).  Interestingly,  Loc1  has  also  been  found  to  associate  with  a  nucleolar intermediate  of  a  large  ribosomal  subunit  precursor  (Harnpicharnchai  et  al., 2001).  In  order  to  confirm  presence  of  Loc1  in  the  nucleolus,  I  analyzed  Loc1 distribution by fluorescence microscopy. 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With  two  different  approaches,  I  detected  a  tagged  version  of  Loc1  either  by indirect  immunofluorescence  or  by  green  fluorescent  protein  (GFP)  live  imaging (Figure 6). The Loc1‐signal was crescent‐shaped in both experiments (Figure 6A, E, G) and entirely confined inside a region of the nucleus stained with DAPI (Figure 6C, D),  suggesting  nucleolar  localization.  In  addition,  the  Loc1‐HA6  signal  largely overlapped with a nucleolar marker, the yeast homolog to fibrillarin (Nop1, Figure 6B, D).  Since  Loc1  is  implicated  in  ribosome biogenesis  (Urbinati  et  al.,  2006),  a  central process in all eukaryotes, I wondered whether it is a conserved protein. I  performed  a  BLAST  search  with  the  S.  cerevisiae  Loc1  amino  acid  sequence deposited in GenBank (Accession NP_116656; Altschul et al., 1997; Altschul et al., 2005).  The  amino  acid  sequence  has  no  regions  with  high  homology  to  known conserved  domains.  All  sequences with  high  alignment  scores  (≥  80  bits)  in  the BLAST  search  were  proteins  from  the  order  Saccharomycetales  (Hibbett  et  al., 2007) and are mostly hypothetical proteins. The eight closest homologs (bit score 




Sce MAPKKP---SKR--QNLRREVAPEVFQDSQARNQLANVPHLTEKSAQRKPSKT  48
Cgl MGSIKK---TKGKSQSTKRVVTPEVFADQQARNQLANAPNLTEKSERRKANKL  50
Vpo MAVKKS---SKG--QQTRREVRPEVFQDKQARNQLANVPQLTEKSAHKKPNKL  48
Ego MAGKQTKTAKRAKTQNRTREVTSEVFQDSQARNQLANAPKV-EKPSARKATKR  52
Kla MAPKQSKTAKRSKKQNGTREVRSEVFEDSIAKNQMANVPKMTEKSDTKKPTKL  53
Lel MAPRQSQTAKRNKTQNKTRENESEVFLDSAARNLLENQPKLAAKSKVKKLSKL  53
Cal MAPRQSKTAKRNKTQNKTRTVDSEVFSDSAAKNLLADQPKLTPKSKVKKISKL  53
Dha MAPRQSKTAKRSKVQNKTRTVESEVGSDSAARNLLMSQPKLTPKSIVKAPSKA  53
Pst MAPRQSKTAKRSKTQNKTRANESEVFSDASARNLMANQPKLTEKSKVKKLSKR  53



































Figure 7   Loc1 is predicted to contain α-helices and shows sequence conservation 
within mostly hypothetical proteins of the Saccharomycetales.  Secondary structure prediction for the Saccharomyces cerevisiae Loc1 amino acid sequence (Sce, in bold;  GenBank  accession  NP_116656)  has  been  carried  out  using  Jpred  3  (Cole  et  al.,  2008). Predicted β‐sheets are shown as orange arrows, predicted α‐helices as  red bars. Sequences were aligned with Clustal W2 (Larkin et al., 2007), using the eight most closely related proteins. These were  identified  by  a  BLAST  search  against  the  nr  database  (BLASTP2.2.19+,  Score  ≥  150  bits; Altschul et al., 1997; Altschul et al., 2005) and most of them are hypothetical proteins. Conserved aminoacids  are  shown  in  blue  and  marked  by  an  asterisk  below  the  sequences.  In  addition, conserved substitutions are indicated by a colon, and semi‐conserved substitutions by a dot.  Cgl  Candida  glabrata  (XP_446071);  Vpo  Vanderwaltozyma  polyspora  (XP_001645367);  Ego 
Eremothecium  gossypii  (NP_986666);  Kla  Kluyveromyces  lactis  (XP_454593);  Lel  Lodderomyces 
elongisporus  (XP_001526360);  Cal  Candida  albicans  (XP_721719);  Dha  Debaryomyces  hansenii (XP_459244); Pst Pichia stipitis (XP_001387044).  
2.2. The PUF family protein Puf6 localizes predominantly to the 
nucleolus Proteins  of  the  PUF  family,  named  after  Drosophila  melanogaster  Pumilio  and 




Figure 8   Puf6 localizes predominantly to the nucleolus. A‐D Cells expressing a HA6‐tagged version of Puf6 were stained by indirect immunofluorescence with antibodies directed against HA (A) and the nucleolar marker Nop1 (B). Nuclei were visualized with DAPI (C). Overlap of Puf6 and Nop1 staining in a distinct region of the nucleus (D)  indicates nucleolar localization of Puf6. E‐H  Live imaging of cells expressing Puf6‐GFP. The crescent‐shaped GFP‐signal (E) in the central region of the cells (F) suggests nucleolar localization of the protein. (G, H) Blow‐up of a single cell from images E and F (white square). 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In order to identify protein interactors of Loc1 and Puf6, respectively, I added the TAP‐tag  to  the  C‐terminus  of  either  protein. While  Puf6‐TAP  grows  at wild  type levels,  Loc1‐TAP  shows  temperature  sensitivity  at 37°C  (Figure 9A). Therefore,  I added the TAP‐tag to the N‐terminus of Loc1, which restored growth at 37°C, but lead to a mild growth defect at all temperatures tested (Figure 9A). Purification of Puf6‐ and Loc1‐, but not of Hpr1‐associated complexes under  low salt conditions yielded  a  large  number  of  interacting  proteins  (Figure  9B,  left).  The  Puf6‐  and Loc1‐associated  complexes  were  very  stable  at  higher  salt  concentrations  and could  only  be  disassembled with  1 M  salt  (Figure  9B,  right).  Bait  proteins were identified by mass‐spectrometry (except for Hpr1 and Loc1 (low salt)). For Puf6, I could  additionally  confirm  two  published  interacting  proteins,  Drs1  and  Cbf5 (Table 2; Gavin et al., 2006).  
Table 2   Proteins from tandem affinity purifications  
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Figure 9   Loc1 and Puf6 purify a large protein complex. A    Initial  characterization  of  TAP‐strains.  A  strain  expressing  Puf6  with  a  C‐terminal  TAP‐tag grows like wild type (W303) at all temperatures tested. In contrast, a strain expressing Loc1 with a C‐terminal TAP‐tag  is  temperature‐sensitive at 37°C; N‐terminal  tagging  results  in a mild growth defect at all temperatures tested. This strain was used for all Loc1 purifications. For dot tests, cells were spotted in serial dilutions onto YPD and incubated at the respective temperature for 3 days. B   Tandem affinity  purification  of  Loc1  and Puf6  at  100 mM NaCl  (low  salt,  left)  and 1 M NaCl (high  salt,  right),  respectively.  Unlike  the  control  Hpr1  (bait  marked  with  squares),  both  Puf6 (circles)  and  Loc1  (asterisks)  purify  with  several  proteins  that  most  likely  represents  a  60S ribosomal subunit precursor (see e.g. Horsey et al., 2004 for comparison). This complex dissociates from the respective bait proteins only under high salt conditions. Novex Bis‐Tris 4%‐12% gradient gels were used for SDS‐PAGE and stained with colloidal Coomassie blue. C  Western blot analysis shows interaction of Puf6 with Loc1, but not with She2. Tandem affinity purification of Puf6; SHE2 and LOC1 have either been deleted or tagged at the C‐terminus. While the Loc1‐HA3  signal  is  clearly  visible  in  the Western  blot,  no  signal  for  She2‐myc9  can  be  detected. Vertical line indicates cutting of membrane for different antibody incubations.   
2.4. Loc1 and Puf6 influence mRNA localization Both  Loc1  and  Puf6  were  first  identified  as  RNA‐binding  proteins  that  are implicated  in  localization  of  ASH1  mRNA.  Puf6  was  found  in  tandem  affinity purifications  of  She2‐TAP  (Gu  et  al.,  2004),  and  Loc1  was  identified  in  a  yeast three‐hybrid  screen  using  the ASH1  localization  element  E3  as  bait  (Long  et  al., 2001).  In  a  first  approach,  I  wanted  to  confirm  the  published  data  on  the participation of Loc1 and Puf6, respectively, on ASH1 mRNA localization. I  created  strains  with  deletions  of  either  LOC1  or  PUF6,  carrying  a  high‐copy number  plasmid  expressing  ASH1  to  alleviate  finding  cells  with  ASH1  mRNA signals, and performed fluorescent in situ hybridization (FISH, see section 5.5.3). I counted late anaphase cells, where nuclei of mother and daughter cell are already largely separated, and clustered them into three groups: cells where a clear mRNA signal  could be observed at  the  tip of  the daughter cell  (bud‐tip  localized, Figure 10A),  cells  where  the  mRNA  signal  was  enriched  in  the  daughter  cell,  but  not anchored  at  the  tip  (bud  enriched,  Figure  10B),  and  cells  with  no  detectable enrichment  of  RNA  anywhere  in  mother  and  daughter  cell  (delocalized,  Figure 10C).  The  first  category  was  scored  as  localized,  the  other  two  as  delocalized. Statistical analysis showed that deletion of PUF6  leads to a moderate decrease of cells  correctly  localizing  ASH1  mRNA  from  about  70%  in  wild  type  cells  to approximately 50% in Δpuf6 cells (Figure 10G). In contrast, deletion of LOC1 has a dramatic effect on ASH1 mRNA localization. In Δloc1 cells, only one fifth of all cells counted have ASH1 mRNA localized correctly at the bud tip, whereas in about 80% 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of  the  cells  the  signal  was  uniformly  distributed  over mother  and  daughter  cell (Figure 10G).  
 







































Both observations are in accordance with the mentioned studies, where 42±5.1% of Δpuf6  cells  and  13%  of Δloc1  cells  have  been  shown  to  localize ASH1 mRNA properly at the bud tip (Gu et al., 2004; Long et al., 2001). In  conclusion,  I  could  confirm  the  available  data  on ASH1  mRNA  localization  in 
Δloc1 and Δpuf6 cells.  It  was  shown  above  that  Loc1  and  Puf6  are  predominantly  nucleolar  proteins (Figure  6;  Figure  8),  and  there  is  data  connecting  both  proteins  to  ribosome biogenesis  (Nissan  et  al.,  2002;  Urbinati  et  al.,  2006;  see  section  2.5).  I hypothesized that other nucleolar, nonessential ribosome biogenesis factors might participate in localization of ASH1 mRNA as well. Therefore, I created strains with deletions  of  MRT4  (for  mRNA  turnover)  and  NOP16  (for  nucleolar  protein), respectively (Harnpicharnchai et al., 2001; Zuk et al., 1999). Counting and scoring of cells after FISH of ASH1 mRNA was performed as described above. Data analysis showed that in contrast to Puf6 and Loc1, Mrt4 and Nop16 do not seem to play a significant  role  in  localization  of  ASH1  mRNA.  Deletion  of  MRT4  leads  to  a reduction of cells correctly localizing ASH1 mRNA by approximately 10%. Deletion of NOP16 has no effect at all, though data derives from a single experiment (Figure 11).  
 
Figure 11   Deletion of MRT4 has a mild, deletion of NOP16 no effect on localization of 
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Having analyzed additional protein factors, I stepped back to Loc1 and Puf6. ASH1 mRNA  is  the  paradigm  of  a  localizing  mRNA,  but  in  total  there  are  about  30 localized mRNAs in yeast (see Table 1, Aronov et al., 2007; Shepard et al., 2003). So far, a role for Loc1 has only been demonstrated in localization of ASH1 mRNA, and it is unclear if localization of other mRNAs depends on Loc1 as well.  Therefore,  I  decided  to  investigate  localization of  two other mRNAs  in wild  type and Δloc1  cells,  because  a  deletion  of  LOC1  showed  the most  dramatic  effect  in 
ASH1 mRNA localization (Figure 10).  
IST2  mRNA  (for  increased  sodium  tolerance;  Entian  et  al.,  1999)  has  been identified  in a whole‐genome analysis of  transcripts associating with She2, She3, and Myo4 (Takizawa et al., 2000). In contrast to ASH1 mRNA, which is expressed only  during  mitosis,  IST2  mRNA  is  not  regulated  during  cell  cycle.  The  mRNA encodes a protein that localizes to the plasma membrane of the daughter cell and not to the nucleus (Shepard et al., 2003; Takizawa et al., 2000).   I  created  the  required  strains by  transforming either wild  type or  loc1 knockout cells with a high‐copy number plasmid expressing IST2 under its own promoter to facilitate microscopy; IST2 overexpression did not influence cell growth (data not shown).  Subsequently,  I  performed  FISH  analysis  of  wild  type  and  Δloc1  cells. Here,  only  small  buds  with  a  size  of  up  to  one  third  of  the  mother  cell  were counted,  since  the  IST2  mRNA  signal  was  not  detectable  in  large‐budded  cells (Figure 12A‐F). In contrast to FISH analysis of ASH1 mRNA, cells displaying signals enriched in the bud were not  scored as delocalized because  it was often difficult  to discriminate between  bud‐tip  localized  and  bud  enriched  signals  (Figure  12G).  Scoring  of signals  into  the  described  categories  showed  that  although  the  overall  effect  of 
LOC1 deletion on localization of IST2 mRNA is less prominent as compared to ASH1 mRNA, a clear reduction of cells with a correctly localized IST2 signal from about 30% in wt cells to about 18% in Δloc1 cells can be observed (Figure 12G).  The third mRNA I tested for localization defects in Δloc1 cells is WSC2 mRNA (for cell  wall  integrity  and  stress‐response  component;  Verna  et  al.,  1997).  It  was identified  as  a  bud‐localized  transcript  in  a  study  that  further  developed  the microarray‐based  screen  method  mentioned  previously  (Shepard  et  al.,  2003; 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Takizawa et al., 2000) and codes  for an  integral membrane protein. WSC2 mRNA differs from IST2 mRNA in that it  is cell cycle‐regulated, and from ASH1 mRNA in that it is induced during S phase (Shepard et al., 2003).   
 



































localized bud enriched delocalized



















localized bud enriched delocalized


























FISH with DIG‐labeled probes was performed as described  in  section 5.5.3.  Cells showing fluorescent signals were selected, counted and scored analogous to IST2 mRNA. The results are shown in Figure 13. As for IST2 mRNA, considerably fewer wild type cells as compared to FISH analysis of  ASH1  mRNA  showed  bud‐tip  localization  (see  Discussion).  Nonetheless,  a significantly  smaller  amount  of  Δloc1  cells  (approximately  16%)  show  correct 
WSC2 mRNA localization, as compared to wild type cells (approximately 32%). On the other hand, significantly more Δloc1 cells have a completely delocalized WSC2 mRNA signal (Figure 13G).  To summarize, I have demonstrated that deletions of PUF6 and LOC1, respectively, lead to reduced localization of ASH1 mRNA. I have further shown that deletion of the  nucleolar  factor  MRT4  also  has  an  effect  on  localization  of  ASH1  mRNA, whereas deletion of NOP16 does not. Finally, I observed that Δloc1 cells also have significant defects  in  localization of  two other  localizing mRNAs,  IST2  and WSC2, respectively. 
2.5. Loc1 and Puf6 participate in ribosome biogenesis The main function of the nucleolus is the synthesis of pre‐ribosomal subunits (see Introduction).  We  have  already  seen  that  both  Puf6  and  Loc1  localize  pre‐dominantly  to  this  nuclear  compartment  (sections  2.1,  2.2).  Data  from  genome‐wide  studies  indicate  that  both  proteins  interact  with  a  variety  of  ribosomal proteins and non‐ribosomal factors involved in ribosome biogenesis (Gavin et al., 2006;  Gavin  et  al.,  2002).  These  data  have  been  confirmed  by  a  number  of additional  studies, where Puf6, Loc1, or both have been  found  in purifications of nucleolar ribosome biogenesis factors (Harnpicharnchai et al., 2001; Horsey et al., 2004; Nissan et al., 2002; Saveanu et al., 2003; Saveanu et al., 2007).  
2.5.1. Loc1 and Puf6 are large subunit biogenesis factors A very common method to get insight into the role of a specific protein in ribosome biogenesis  described  in  the  literature  is  the  analysis  of  polysome  profiles (Rotenberg  et  al.,  1988).  In  a  study  that  investigated  yeast  66S  pre‐ribosomal particles by affinity purification of one central component, Nop7, several proteins not  previously  assigned  to  have  a  role  in  ribosome  biogenesis  were  identified. Their  function was assayed by depletion of  the proteins and subsequent  sucrose 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density gradient centrifugation (Harnpicharnchai et al., 2001). In order to use this system,  I  first  performed  sucrose  density  gradient  centrifugation  of  strains with deletions  of  two  of  the  factors  analyzed  in  this  study,  MRT4  and  NOP16, respectively,  as  a  proof  of  principle.  Subsequently,  I  subjected Δpuf6  and Δloc1 cells to this analysis.  I used the Δmrt4 and the Δnop16 strain that had already been analyzed for their phenotype  on  ASH1  mRNA  localization  (section  2.4),  but  without  the  ASH1 plasmid.  In  addition,  I  also  analyzed  a  strain  lacking  a  small  subunit  biogenesis factor, LTV1 (for low temperature viability; Seiser et al., 2006). The Δnop16 strain grew normally at all temperatures tested, Δltv1 cells grew only at 24°C, and Δmrt4 cells showed a slow growth phenotype at both 24°C and 37°C (Figure 14A).  Analysis  of  the  polysome  profiles  confirmed  that  disruption  of  the NOP16  gene does  indeed  impair,  albeit  relatively weakly,  ribosome  biogenesis. While  in wild type  cells  (Figure 14C)  the 60S peak was  always higher  as  compared  to  the 40S peak, peak heights are almost identical in Δnop16 cells (Figure 14G). Moreover, the 















































































































































































Figure 14   Deletion of LTV1 impairs biogenesis of the small ribosomal subunit, deletion of 
LOC1, MRT4, NOP16 or PUF6 impairs biogenesis of the large ribosomal subunit to different 
extents. A  MRT4 knockout cells show slow growth at all  temperatures  tested, whereas deletion of LTV1 leads to a temperature sensitive phenotype;  in contrast, deletion of NOP16 has no apparent effect on cell growth at all. Cells were spotted in serial dilutions onto YPD and incubated for 3 days at the respective temperature.  B  Deletion of LOC1 leads to slow growth, whereas deletion of PUF6 has no effect on growth. Cells were spotted in serial dilutions onto YPD and incubated for 3 days at 30°C.  C‐H  Polysome profiles of a wild type (wt) and various ribosome biogenesis factor deletion strains. Deletion of  the  small  subunit  biogenesis  factor LTV1  leads  to  a  profile  that  differs  from all  other profiles  shown. Here, 40S peak  size  (marked by  squares)  is  slightly  reduced as  compared  to 60S (marked by asterisks), polysome peak sizes  (marked by bars) are reduced, and all peaks starting from the 80S peak (marked by circles) seem slightly inclined to the left as compared to wt (D).  Profiles  of  Δmrt4  and  Δloc1  are  similar  to  one  another  (E,  F).  The  respective  60S  peaks  drop significantly below the 40S peak, 80S peak size  is greatly reduced, and polysome peaks are much less prominent as compared to wt. In addition, so‐called half‐mers appear (see text for details). Deletion of NOP16 and PUF6, respectively, leads only to a moderate reduction in 60S and 80S peak size, and has nearly no effect on polysome peaks (G, H). Profiles were collected from 300 µg total RNA loaded onto 7‐47% linear sucrose gradients. All profiles were normalized, so that the lowest point in the valley between 40S and 60S corresponds to 0.   Subsequently,  I  performed  sucrose  density  centrifugation  with  total  RNA  (see section 5.2.4). Consistent with the growth phenotype, deletion of PUF6  leads to a mild defect in 60S subunit biogenesis, similar to deletion of NOP16. Peak heights of free  large subunits and monosomes,  respectively, are diminished, and weak half‐mers  can  be  observed  (Figure  14H).  In  contrast,  the  Δloc1  profile  very  much resembles  the one obtained  for Δmrt4.  It  shows a  small 60S peak  relative  to  the 40S peak,  a  strongly  reduced number  of monosomes,  and pronounced half‐mers (Figure 14E).  Taken  together, my  data  suggest  that  deletion  of  LOC1  and,  to  a  smaller  extent, deletion  of  PUF6,  leads  to  a  deficiency  in  large  ribosomal  subunits.  Further experiments  showed  that  this  deficiency,  at  least  in  the  case  of  LOC1,  is  indeed caused by depletion of Loc1 and not by slow growth of the cells (see section 2.8.3) 
2.5.2. Deletion of Loc1 delays large subunit rRNA processing The  nucleolar  steps  of  ribosome  biogenesis  involve  a  large  number  of  protein rearrangements  and  RNA  processing  steps  (see  Introduction).  After  having confirmed  that  Puf6  and  Loc1  function  in  this  pathway,  I  wanted  to  investigate whether  they  are  required  for  specific  steps  in  rRNA  processing  of  the  pre‐60S subunit.  Thus,  I  looked  at  levels  of  newly  synthesized  rRNA  intermediates  by  in 





Figure 15 Relative abundance of some 
pre-rRNAs changes upon deletion of 
LOC1 or PUF6. A Yeast  cells  were  pulse‐labeled with  3H‐uracil  for  15  min,  and  total  RNA  was extracted.  RNA  corresponding  to  500  cpm was run on a 1% TAE agarose gel to assess RNA  quality  and  control  for  equal  loading. No  degradation  of  the  25S  and  18S  rRNA band  is  visible,  and  loading  is  equal  except for  the Δloc1  lanes, where  the 25S signal  is moderately reduced.  B    Northern  Blot  of  total  RNAs  tested  in (A).  For  wild  type  (wt),  Δloc1,  and  Δpuf6, strains  with  two  different  strain backgrounds  have  been  tested  (BY4741  on the  left side and BY5563 on the right side), the two control strains Δrps4b and Gal‐Flag rpS14B  are  BY4741  derivatives.  Arrow‐heads  mark  changes  in  rRNA‐precursor signal  intensities  as  compared  to  wt. Deletion of LOC1  leads  to slightly  increased levels  of  35S  and  27S  pre‐rRNAs,  whereas 25S  rRNA  levels  are  reduced  (Sébastien Ferreira‐Cerca,  personal  communication). Deletion  of  PUF6  leads  to  a  very  weak phenotype,  showing  slightly  increased levels of 32S pre‐rRNA (Sébastien Ferreira‐Cerca,  personal  communication).  In contrast, both control strains show 35S pre‐rRNA  accumulation,  a  strong  decrease  in 20S pre‐rRNA levels, and Gal‐Flag‐rpS14B in addition  a  reduced  27S  pre‐rRNA  levels (Ferreira‐Cerca  et  al.,  2005).  For  the  Blot, 10,000  cpm  were  run  on  a  1.3% MOPS/formaldehyde  agarose  gel, transferred onto a positively charged Nylon membrane  and  exposed  to  a PhosphoImager screen for 2 days.  
Consistent with results in previous sections, deletion of PUF6 leads only to a weak phenotype that is hard to distinguish from wild type. The only significant change in 













































ribosomal particle, and of a 27S pre‐rRNA species. Levels of mature 25S rRNA are reduced, indicating a delay in large subunit rRNA processing. In  summary,  in  vivo  pulse  labeling  confirms participation of  Loc1  in 60S  subunit biogenesis and suggests that it is required at the stage of 27S rRNA processing, i.e. at late nucleolar steps of pre‐60S maturation. 
2.5.3. Total amount of ribosomes is reduced in Δ loc1 cells The  results  described  in  this  study  so  far  have  confirmed  a  role  for  Loc1  in  the maturation of pre‐60S ribosomal particles. Since deletion of LOC1 leads to a delay in processing of rRNAs of the large subunit, fewer mature large ribosomal subunits are  available  at  a  given  time point.  In  order  to  counteract  this deficit  and not  to synthesize excess amounts of small subunits that are not needed, one would expect that  cells  reduce  small  subunit  synthesis  as  well.  To  test  this  hypothesis,  I compared  the  amounts  of  large  and  small  ribosomal  subunits  in  wild  type  and 




Figure 16   Cells without Loc1 contain 
less ribosomal subunits than wild type 

































a  Δloc1  strain,  as  indicated  by  the  presence  of  half‐mers  in  Δloc1  polysome profiles. To summarize, my results indicate that Δloc1 cells contain excess small relative to large  ribosomal  subunits,  and  the  total  number  of  ribosomes  appears  to  be reduced.  
2.6. ASH1 mRNA is translationally silenced in the nucleolus 





Figure 17   She2 and ASH1 mRNA accumulate in the nucleolus when mRNA export is 
blocked. A‐H  She2 accumulates  in nucleoli upon mRNA export block. Cells expressing the wild type (wt) allele of the mRNA export factor Mex67 (MEX67, A‐D) or a temperature‐sensitive (ts) mutant allele (mex67­5, E‐H) were stained by indirect immunofluorescence with antibodies directed against She2 (A, E) and the nucleolar marker Nop1 (B, F). Nuclei were visualized with DAPI (C, G). Both cultures were  shifted  to  the  restrictive  temperature  (37°C)  for  one  hour,  and  ASH1  mRNA  was overexpressed by galactose induction. She2 localizes to the bud‐tip in MEX67 cells (A, D). However, in mex67­5  cells,  She2  and  Nop1  signals  overlap  in  a  region  of  the  nucleus,  indicating  nucleolar accumulation of She2. I‐N    ASH1  mRNA  accumulates  in  nucleoli  upon  mRNA  export  block,  if  the  nuclear  exosome  is inhibited. Cells expressed either wt MEX67 (I‐K) or the ts‐allele mex67­5 with an additional deletion of RRP6  (L‐N). They were stained by double FISH after shift  to 37°C and ASH1 overexpression by galactose  induction  for one hour.  ITS2 serves as a marker  for  the nucleolus  (see  text  for details). Nuclei were visualized with DAPI.  Again,  in MEX67  cells ASH1  mRNA  localizes  to  the  bud  tip,  whereas  in mex67­5/Δrrp6  cells,  the signals of ASH1 and ITS2 RNAs largely overlap, indicating nucleolar accumulation of ASH1 mRNA.  All data shown in this figure from Du, 2007 and Du et al., 2008, respectively. 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In  addition,  a  nuclear  spot,  possibly  indicating  the  ASH1  transcription  site,  was observed  (Du  et  al.,  2008).  The  rRNA  sequence  ITS2,  which  is  present  only  in nucleoli (see section 1.2), was used as a marker for the nucleolus (Figure 17M).  Upon block of mRNA export and additional deletion of RRP6 (for ribosomal RNA processing; Briggs et al., 1998), a gene encoding a subunit of the nuclear exosome (Hilleren et al., 2001), the signal for ASH1 mRNA largely overlapped with the ITS2 signal, indicating nucleolar localization (Figure 17L, N; see Discussion).  
2.6.2. Cytoplasmic retention of She2 influences Ash1 distribution With  the  proof  that  She2  and  ASH1  mRNA  can  enter  the  nucleolus  and  the assumption  that  this  represents  an  intermediate  step  in  the  maturation  of localizing  mRNPs  under  physiological  conditions,  we  wanted  to  elucidate  the functional relevance of nucleolar passage of She2.  Tung‐Gia  Du  started  to  tackle  this  question  and  created  a  fusion  protein  that trapped She2 in the cytoplasm. The obvious candidate for the cytoplasmic anchor was  the  N‐terminal  part  of  She3  (She3N),  which  binds  strongly  to  the  motor protein Myo4 (Heuck et al., 2007). The resulting  fusion protein She3N‐She2 does not enter the nucleus (Du et al., 2008). Quite contrary to the hypothesis that this nuclear  exclusion  would  perturb  ASH1  mRNA  localization,  he  observed  correct 




Figure 18 Loss of asymmetric Ash1 distribution in She3N-She2 cells can be rescued by 


























































(continued: Figure 18) cell  nuclei  (symmetric, D). Only  post‐anaphase  cells,  i.e.  cells with  large  buds, where  nuclei  have already separated, were counted.  H  Ash1‐myc9 distribution as determined by IF  in Δshe2. Cells were transformed with a plasmid carrying  ORFs  coding  for  either  SHE2,  the  SHE3N­SHE2  fusion  protein,  or  the  fusion  protein preceded by a double nuclear localization sequence (2×NLS‐SHE3N‐SHE2). While in wt (She2) cells Ash1  distribution  is  about  one  third  for  each  category,  roughly  half  of  the  She3N‐She2  cells (51±8.1%)  have  a  symmetrically  distributed  Ash1  signal.  Addition  of  a  double  NLS  to  the  N‐terminus of the fusion results in wt‐like distribution. The collected data are statistically significant, as determined by a χ2 test (n(SHE2)=310; n(SHE3N‐SHE2)=363; n(2×NLS‐SHE3N‐SHE2)=361; She2 vs. fusion: P<10‐7; She2 vs. 2×NLS fusion: P<10‐4; fusion vs. 2×NLS fusion: P<10‐18).  In order to prove that the reason for the altered Ash1 distribution in She3N‐She2 cells is in fact cytoplasmic retention of She2, I pursued three strategies. First,  I  tried  to  find  a  She2 mutant  that  would  show  the  desired  phenotype,  i.e. exclusive  cytoplasmic  localization.  I  had  indications  that  the  extreme  C‐terminal part of She2  is  important  for nuclear  localization (Böhl, 2001). Thus,  I created C‐terminal  truncations  of  wild  type  She2  and  the  RNA‐binding  mutant  of  She2 (N36S‐R63K; Du et al., 2008). I used a plasmid expressing the respective version of GFP‐She2 under its endogenous promoter and monitored localization of the fusion protein by live imaging (Figure 19). Full‐length wild type She2 was detected at the bud‐tip, with some additional signal in  the  nucleus, while  the RNA‐binding mutant  of  She2 was  observed  only  in  the nucleus (Figure 19A‐D). Removal of ten amino acids from the C‐terminus caused a relocation  of  wild  type  She2  to  the  nucleus,  the  mutant  remained  unaffected (Figure  19E‐H).  When  I  truncated  the  protein  further,  I  could  not  detect  any fluorescence signal (Figure 19I‐L). I  conclude  that  nuclear  exclusion  cannot  be  achieved  by  a  simple  C‐terminal truncation of She2.  As  a  second  approach,  I  tried  to  create  fusion  proteins  independent  of  the described She3N‐She2. Therefore,  I  fused She2 to other protein domains that are sequestered  to  the  cytoplasm.  All  fusions  were  created  on  plasmids  and transformed into a strain with a deletion of SHE2 but otherwise wild type. Under these conditions, She2 fusions suitable  for  further experiments should  localize to the  bud  tip,  as  does  the  control  plasmid  expressing  She2  alone  (Figure  20A,  B). Localization  was  assessed  by  indirect  immunofluorescence  with  an  antibody directed against She2 (Du et al., 2008). 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WHI3  (for Whiskey, Nash et al., 2001) encodes a RNA‐binding protein, which has been  described  to  sequester  CLN3  mRNA  to  distinct  regions  in  the  cytoplasm.  I tried  to  fuse  full‐length  Whi3  to  both  ends  of  She2,  but  never  succeeded  in expressing a fusion protein. 
 
MOD5  (for  tRNA modification)  codes  for  two  isoforms  –  the  shorter  one  lacking twelve  amino  acids  from  the  N‐terminus  –  of  a  transferase  implicated  in isopentenylation  of  tRNAs  (Dihanich  et  al.,  1987;  Tolerico  et  al.,  1999).  After removal of a nuclear localization sequence (NLS) from the extreme C‐terminus, the shorter second  isoform Mod5‐II  localizes  to  the cytoplasm, even when  fused to a reporter  construct  consisting  of  β‐galactosidase  and  a  part  of  histone  H2B  (so‐called karyophilic β‐galactosidase, Tolerico et al., 1999). Thus, I created a plasmid expressing a  fusion of Mod5‐II  lacking  the NLS  to  the C‐terminus of  She2  (She2‐Mod5)  and  performed  immunofluorescence.  In  contrast  to  She2,  She2‐Mod5  is ubiquitously  distributed  throughout  mother  and  daughter  cell;  hence  it  is  not suited for further experiments (Figure 20E, F).  




Figure 19   C-terminal truncations of She2 interfere with its localization. A‐D   Live  imaging  of  full  length  GFP‐She2  in  wild  type  (wt;  A,  B)  or  N36S‐R63K  double  point mutant cells (C, D), which cannot bind RNA (Du et al., 2008). While GFP‐She2 localizes to the bud tip in wt cells (A), it is trapped in the nucleus in the RNA‐binding mutant (C). E‐H  Deletion of 10 amino acids (aa) from the C‐terminus leads to relocation of GFP‐She2 to the nucleus in wt cells (E, F), but has no effect on localization of GFP‐She2 in the RNA‐binding mutant (G, H).  I‐L  Deletion of 20 amino acids  from the C‐terminus abolishes  localization and/or expression of GFP‐She2 in all strains tested.       I thought that I might rescue the impaired Ash1p distribution in She3N‐She2 cells if I allowed the protein to enter the nucleus again, for example by adding a nuclear localization  sequence  (NLS).  Insertion  of  a  tandem  simian  virus  40  (SV40)  NLS (2×NLS;  Kalderon  et  al.,  1984)  between  She3N  and  She2  had  no  effect  on  Ash1 protein  distribution  (Tung‐Gia  Du,  personal  communication).  Therefore,  I  added the  2×NLS  to  the  5´‐end  of  the  SHE3N­SHE2  fusion  construct.  Subsequently  I analyzed  localization  of  She2  and  found  that  it  is  not  altered  by  this  additional fusion  (Figure  20C, D). When  I  looked  at  Ash1  in  a  strain  transformed with  this new construct, I saw that loss of asymmetric distribution is in fact reversed by the addition of a 2×NLS (Figure 18H). 
A
4!m
GFP-She2 DIC GFP-She2 DIC
B C D
E F G H























Figure 20   Fusion of 2×NLS-
She3N to She2 does not affect 
protein localization. She2 has been fused with different protein domains in order to trap it in the cytoplasm. Cells  expressing  the  respective fusion proteins from a centromeric plasmid  were  stained  by  indirect immunofluorescence  with  an antibody directed against She2 (A, C, E, G,  I). Only  cells with  small  to medium  sized  buds,  as  judged  by differential  interference  contrast (DIC; B, D, F, H, J), were analyzed.  Addition  of  a  double  nuclear localization  sequence  and  the  N‐terminal  part  of  She3  (2×NLS‐She3N)  to  the N‐terminus  of  She2 enhances its localization to the bud tip  (C, D) as compared  to  the wild type  protein  (A,  B).  Fusion  of  the short  isoform of Mod5  lacking  the C‐terminal  NLS  to  the  C‐terminus of  She2  leads  to  ubiquitous cytoplasmic  distribution  of  She2 (E,  F).  A  fusion  of  the  cytoplasmic anchor domain of  Stp1  (Stp1_I)  to the  She2  N‐terminus  is  not expressed and therefore leads to a 
Δshe2 phenotype (G, H). However, if  three  copies  of  this  domain  are fused  to  the  N‐terminus  of  She2, particles  seem  to  form  but  get stuck  at  the  bud  neck  (I,  J). Arrowheads mark buds. 



























Figure 21 Ash1 synthesis is accelerated in cells expressing the She3N-She2 fusion 
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(continued: Figure 21) B  ASH1  mRNA  levels  are  induced  by  addition  of  galactose.  Cells  of  the  indicated  strains were grown to log‐phase in raffinose‐containing medium, then ASH1 expression was induced by addition of 4% (v/v) galactose. Samples of the cultures were taken at 0, 5, 10, 15, 30, and 60 min after shift and processed for Northern and Western Blotting, respectively. The depicted Northern Blot shows a roughly similar  induction in all strains (for quantification see below). ASH1 mRNA signals could be  detected  from  time  point  5  min  onwards.  ASH1  mRNA  signals  were  normalized  to  a  cross‐reacting unspecific band (triangle). C  All mutants tested show an accelerated Ash1 synthesis as compared to wild type (wt). For all mutant  strains  the  Ash1‐myc9  signal  at  60  min  after  shift  is  much  stronger  than  in  wt  cells,  as detected by Western Blot analysis. Signals were normalized to actin levels. D – F  Quantification of Western Blots. Normalized Ash1  signals were plotted against  time. The charts show that although induction is comparable to some extent – wt (black circles) induction is the  weakest,  Δshe2  (red  circles)  induction  the  second  weakest  –  levels  of  induction  for  the remaining mutants differ, and  induction kinetics are different between single experiments (y‐axis range 0‐1.75 in D, 0‐3.5 in E and F). G – I  Quantification of Northern Blots. Like Ash1 protein, also ASH1 mRNA kinetics can differ in overall  signal  intensity,  as  shown  by  Northern  Blot  (y‐axis  range  0‐16  in  G,  0‐8  in  H  and  I). However, similarities are also obvious: Δshe2 cells show the strongest induction, wt cells and cells expressing  the  She3N‐She2  fusion  (orange  circles)  the weakest.  Normalized ASH1 mRNA  signals were plotted against time. J  –  L   Signal  ratio  of  single Western Blots  to Northern Blots.  The  charts  clearly  show  that  cells expressing  the  She3N‐She2  fusion  protein  have  synthesized  approximately  twice  as  much  Ash1 protein  after  60 min  induction  than  all  other  strains  tested.  In Δpuf6  (green  squares)  and Δloc1 cells (blue squares), Ash1 synthesis is accelerated as well. By contrast, Ash1 synthesis in Δshe2 cells is  almost  identical  to wt.  The  outlying  values  for  pSHE3N‐SHE2  at  15 minutes  in K  and L  derive from the relatively low Northern signal for this strain at this time point (H, I). Note that the y‐axis range of chart J is only 10% of the range of charts K and L. 
2.7. Loc1 does not inhibit ASH1 mRNA translation directly Our data on a possible role of Loc1 in translational regulation of the ASH1 mRNP are corroborated by a recent study (Komili et al., 2007). One question that has not been  answered  so  far  is  whether  this  role  is  direct  or  indirect.  A  direct  role  in translational regulation of ASH1 mRNA has been demonstrated  for  the two other accessory  localization  factors  Khd1  and  Puf6  (Deng  et  al.,  2008;  Paquin  et  al., 2007).  Both  proteins  bind  to  the mRNA  and  inhibit  translation  during  transport through  interaction  with  translation  initiation  factors.  In  principle,  this  is  also imaginable for Loc1; on the other hand, it has been convincingly shown that Loc1 is a strictly nuclear protein (Long et al., 2001). My working  hypothesis  to  resolve  this  problem was  the  following:  if  deletion  of Loc1  leads  to  increased  Ash1  synthesis  and  Loc1  exerts  a  direct  role  in translational silencing, then overexpression of Loc1 should lead to decreased Ash1 synthesis.  Hence,  I  created  strains  where  tagged  versions  of  either  the  known direct translational  inhibitor Khd1 or Loc1 were overexpressed from a galactose‐inducible promoter on a plasmid; the empty plasmid served as a negative control. 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Expression  levels  of  both  proteins were  comparable,  as  judged  by Western  Blot (data not shown).  I  followed  Ash1  protein  levels  over  time  by  Western  Blot  (Figure  22). Overexpression  of  Khd1  strongly  reduces  Ash1  protein  levels.  In  contrast, overexpression of Loc1 does not seem to have any effect on Ash1 levels at all. Taken  together,  these  data  indicate  that  Loc1  does  not  have  a  direct  role  in translational silencing of the ASH1 mRNP, consistent with an exclusive nucle(ol)ar localization.   
 




domains In previous sections of  the present  thesis  I have demonstrated  that a deletion of 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Figure 23   The extreme N- and C-terminal parts of Loc1 seem to be dispensable for 
Loc1 function.  A  Schematic representation of a plate assay  to determine  in a  first approximation correct Ash1 protein distribution (red/white screening) and ribosome biogenesis (growth at 37°C). In the strain background  used,  the  ADE2  gene  is  placed  under  control  of  the  HO  promoter,  which  is transcriptionally  repressed  by  Ash1.  In  budding  cells  where  Ash1  is  symmetrically  distributed between mother and daughter  cell nuclei, ADE2  is  repressed and colonies  turn  red  (Jansen et al., 1996). B    C‐terminal  truncations  of  Loc1.  Western  Blot  analysis  shows  that  expression  levels  are comparable for full‐length protein (FL) and truncations up to 84 amino acids (lane 1‐120). Further truncation reduces Loc1 expression (1‐115). The largest truncation (1‐70), where 134 amino acids have  been  removed  from  the  C‐terminus,  is  not  expressed.  Truncations  were  created  by homologous recombination of PCR products as described in section 5.4.3. C    N‐terminal  truncations  of  Loc1.  Plasmids  carrying  N‐terminal  truncations  of  LOC1  were transformed into a Δloc1 strain grown in full medium and analyzed by Western Blot. Only the first truncation, where the N‐terminal 64 amino acids have been removed (65‐204), is expressed.  D   Removal  of  up  to  64  amino  acids  from  the  C‐terminus  seems  not  to  affect  growth  or  Ash1 distribution.  The  plate  assay  shows  that  removal  of  10  additional  amino  acids  affects  growth  at 37°C,  but  seems  to  have  little  effect  on Ash1  distribution,  as  spotted  colonies  remain white  (see Discussion). Further truncation of the C‐terminus affects both growth and Ash1 distribution. A wild type  (wt)  strain  has  been  used  as  negative  control,  a  she2  deletion  strain  (Δshe2)  as  positive control for the red/white selection. E    Removal  of  up  to  64  amino  acids  from  the  N‐terminus  does  not  inhibit  growth.  With  the minimal plates used, which lack leucine to select for the plasmid and low adenine, all colonies were reddish and grew slowly, thus Ash1 distribution could not be tested.  From the data presented above, one could suspect that temperature sensitivity and red  pigmentation  are  coupled.  Therefore,  I  tested  deletions  of  other  mRNA localization  factors  as  well  as  deletions  of  non‐essential  ribosome  biogenesis factors, thereby extending the analysis from section 2.4. Deletion of SHE2 served as control  for  loss  of  asymmetric  Ash1  protein  distribution;  Δshe2  cells  show  the most  intense  red  pigmentation  of  colonies  of  all  factors  tested,  while  growth  at 37°C is barely inhibited (Figure 24A). Disruption of PUF6 does not inhibit growth significantly,  but  cells  are  reddish;  Δkhd1  behaves  as  wild  type  in  this  assay. Interestingly,  some deletions  of  ribosome biogenesis  factors  seem  to  affect Ash1 distribution  (Figure  24B).  A  strain  with  a  deletion  in  NOP16  (see  section  2.4) shows slightly reddish color, but grows like wild type; the phenotype of Δssf1 (for suppressor of swi4, an early 60S biogenesis factor; Fatica et al., 2002) in the plate assay resembles that of Δpuf6. Knockout of the late 60S biogenesis factor ARX1 (for associated with  ribosomal  export  complex; Nissan  et  al.,  2002)  and  the  putative 90S  biogenesis  factor  NOP6  (Fromont‐Racine  et  al.,  2003),  respectively,  cause temperature sensitivity, but do not impair growth at 24°C or Ash1 distribution at all (Figure 24B). Cells carrying a deletion in RRP8 (for ribosomal RNA processing), a  factor  required  for  cleavage  of  pre‐rRNA  at  site  A2  (see  Figure  2;  Bousquet‐
Results 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Antonelli et al., 2000) have a mild growth defect and slight reddish color. Deletion of  the  40S  biogenesis  factor  LTV1  (see  section  2.5.1)  leads  to  temperature sensitivity and  red colonies on plates  containing  low adenine,  and an even more intense color can be observed in Δmrt4 cells, which show a growth defect already at  24°C  as  well.  The  defective  Ash1  distribution  indicated  by  the  red  Δmrt4 colonies is consistent with the impaired ASH1 mRNA localization described above (Figure 11).  
 
Figure 24   Several ribosome biogenesis mutants show defective Ash1 distribution, 
























Taken  together,  the data presented  indicates  that  the extreme C‐ and N‐terminal parts of Loc1 seem to be dispensable for Loc1 function, and no functional protein domains  could  be  identified.  Furthermore,  temperature  sensitivity  does  not necessarily cause red‐colored colonies in the plate assay. 
2.8.2. Rapid and efficient depletion of Loc1 from yeast cultures is 
possible with glucose shut‐off  Truncation  analysis  of  Loc1  showed  that  there  are  no  distinct  protein  domains with  separate  function  in  ribosome  biogenesis  and  mRNA  localization, respectively.  Still,  it  is  imaginable  that  depletion  of  Loc1  would  first  result  in defective  ribosome biogenesis before  impairing ASH1 mRNA  localization. To  test this  hypothesis  of  a  “first  response”,  I  needed  a  system  that  allows  rapid  and efficient depletion of Loc1, preferably within one cell division cycle. A  number  of  ways  to  deplete  proteins  from  cells  have  been  described  in  the literature. Probably the easiest is addition of a drug to the growing culture, which induces  depletion  of  the  desired  protein.  Thus,  I  decided  to  test  a  doxycycline‐regulatable promoter system first (Garí et al., 1997). Here, a tagged version of the 




Figure 25   Control of Loc1 expression with a doxycycline-regulatable promoter is not 
sufficient for rapid, complete depletion. A  Schematic view of the tetracycline‐regulatable promoter construct (Garí et al., 1997). The LOC1 ORF  is  inserted  into  the  MCS  of  a  plasmid  between  a  double  tandem  repeat  of  the  tetracycline operator  (tetO2),  and  a  CYC1  terminator  sequence.  The  transcriptional  transactivator  (tTA)  is controlled  by  a  Cytomegalovirus  (CMV)  promoter.  Both  parts  are  separated  by  the  ADH1 terminator sequence. For all experiments doxycycline (dox) was used, a member of the tetracycline antibiotics.  B   (left  panel) Western  Blot  to  control  for  expression.  Loc1‐HA6  has  a  slightly  lower  apparent molecular weight when expressed from the Tetoff‐plasmid (Tetoff), as compared to a genomic HA6‐tag (wt). The empty plasmid is not detected by the HA‐antibody (ctrl). (right panel) Western Blot of a  Loc1  depletion  time  course.  After  4  h  in  medium  containing  2  µg/ml  doxycycline,  the  signal corresponding to Loc1‐HA6 is greatly reduced as compared to the signal from cells grown without doxycycline. However, depletion is not complete.  Next,  I  tried  depletion  of  Loc1  by  a  heat‐inducible  degron,  which  has  been described to allow very rapid depletion (Sanchez‐Diaz et al., 2004). Here, genomic 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Figure 26   Fusion of Loc1 to a heat-inducible degron is not suited for rapid, complete 
depletion of Loc1. A  Components of the heat‐inducible degron system (Sanchez‐Diaz et al., 2004). The LOC1 ORF is fused with the degron cassette at the N‐terminus. Besides a selection marker (kanMX, not shown), the degron cassette consists of a copper‐inducible promoter (CUP1), followed by the degron, which contains a mutant, temperature‐sensitive version of murine dihydrofolate reductase (DHFRts) and a single myc epitope.  In  addition,  the  ts‐degron  (td)  strain background has UBR1  placed under  the control of a galactose‐inducible promoter (GAL1,10). B Principle of the heat induction to destabilize td‐fused Loc1. The N‐terminal arginine residue (R) is bound by Ubr1/Rad6: This  induces ubiquitylation of exposed  lysine  (K)  residues, which  favors degradation of the fusion protein at 37°C (Sanchez‐Diaz et al., 2004). C  Western Blot to verify an additional C‐terminal HA6‐tag. Loc1‐HA6 has an apparent molecular weight  of  approximately  38  kDa  in  a  wild  type  background  (wt),  and  of  approximately  70  kDa, when fused to the N‐terminal ts‐degron (td). D  Depletion of  td‐Loc1. Serial dilutions of a  loc1 deletion strain (Δloc1),  the degron strain (wt), and the td‐strain of Loc1 were spotted onto plates and incubated at the respective temperature for 3 days. In the presence of high levels of Ubr1 at 37°C, td‐Loc1 cells grow slightly worse as compared to 24°C, suggesting that Loc1 is indeed depleted to a certain extent. Ubr1 expression is very low on plates  containing  glucose  (YPDCu),  but  high  on  plates  containing  galactose  (YPG(Cu)).  Copper  is included in some plates to maintain expression levels of the td‐fusion. E  Western Blot of a td‐Loc1 depletion time course. After 6 h at 37°C in YPG, the td‐Loc1‐HA6 signal is reduced and degradation bands are visible. However, depletion is not complete. 


































































Figure 27   Regulation of LOC1 
expression by a specific Galactose 
promoter can be used to completely 
deplete Loc1 in less than three 
hours. A  Schematic view of the Glucose shut‐off construct. The LOC1 ORF is tagged at the N‐terminus with  3  copies  of  the HA epitope  for  detection  by  Western  Blot, and  placed  under  control  of  either  a shortened version of the GAL1 promoter (GALS,  Janke  et  al.,  2004)  or  the  full length  GAL1  promoter  (GAL1,  Longtine et al., 1998). B GAL1 promoter‐driven HA3‐LOC1 can be  rapidly  depleted  in  glucose‐containing  medium.  Western  Blot analysis  shows  that  the GALS  promoter‐driven Loc1  is depleted completely only after  8  hours  promoter  shut‐off  (left panel). In contrast, Loc1 is not detectable by Western Blot after 3 hours promoter shut‐off  using  the  GAL1  promoter construct. Cells were grown overnight in galactose‐containing  medium  (YPG), diluted  and  grown  for  another generation  in  fresh  YPG,  before  being washed  and  released  into  complete medium  containing  glucose  (YPD). Aliquots were removed from the culture at indicated time points and subjected to Western  Blot  analysis.  An  antibody directed against tubulin has been used to control equal loading. C   Growth  analysis  of  a wild  type  (wt, black)  and  Loc1  depletion  strain (Longtine‐cassette;  blue).  During  the first  two  hours  after  the  shift  to  YPD, both  strains  grow  equally  well. Subsequently,  growth  of  the  Loc1 depleted  cells  slows  down.  Data  comes from three independent experiments. 
2.8.3. Depletion of Loc1 affects ASH1 mRNA localization and ribosome 





































































































































































































































































































Figure 28   Effects of Loc1 depletion on localization of ASH1 mRNA and biogenesis of 
ribosomes seem to be coupled and can be detected after one hour depletion. A  Loc1 is almost completely depleted after 2 hours shift to glucose‐containing medium. Aliquots from cultures of a wt and a Loc1 depletion strain shifted to YPD were taken at indicated time points and subjected  to Western Blot analysis. An antibody directed against  tubulin was used  to control loading. After two hours, the HA3‐Loc1 signal is reduced to roughly 10% of time point 0. B    One  hour  depletion  of  Loc1  causes  significantly  reduced  ASH1  mRNA  localization.  ASH1 localization  of  late  anaphase  cells  from a  culture  immediately  (0  h  depletion)  and one hour  (1  h depletion) after shift to YPD was determined by fluorescent in situ hybridization (FISH; see Figure 10). Whereas 70±5.4% of wild  type  (wt)  cells  localize ASH1 mRNA correctly after one hour, only 61±6.6%  of  Loc1‐depleted  cells  do  so  (n(wt)=144,  n(Loc1  depl.)=113,  P<0.03).  The  phenotype increases with  time,  after  two hours  depletion  only  about  55% of  cells  still  localize ASH1 mRNA correctly.  Error  bars  indicate  standard  deviation  from  three  experiments,  single  experiments without error bars. C‐H  One hour depletion of Loc1 mildly impairs large ribosomal subunit biogenesis. In wild type (wt) cells, profiles of time points 0, 0.5, 1 and 2 hours after shift to glucose are comparable except for a small shoulder in the 80S peak (marked by a circle), which may be caused from the shift itself (C, E, G, I). In Loc1‐depleted cells, the shoulder at 1 hour after shift (H) is much more prominent and can be seen in the disome and trisome peak as well. It corresponds to the half‐mer peak also seen in 





modifications The results shown above suggest that nucleolar transit of ASH1 mRNA is required to ensure  translational  silencing. The nucleolus might not only be  the site where Puf6 is loaded onto the ASH1 mRNP (Deng et al., 2008). It is possible that certain mRNAs  traveling  through  this  nuclear  compartment  might  also  be  modified (Decatur & Fournier, 2003;  see also Discussion),  since one  important  function of the nucleolus is the post‐transcriptional modification of RNAs (Gerbi et al., 2003). The  most  frequent  modifications  are  the  small  nucleolar  RNA  (snoRNA)  guided conversion of uridine to pseudouridine (Ψ) and methylation of 2´‐hydroxyl groups in ribose (Kiss, 2002; Figure 29A).  In order to test the hypothetical presence of modified nucleotides in ASH1 mRNA, I tried  to  set  up  a  published  experimental  system,  but with  the use  of  fluorescent instead of radioactively labeled probes, as described in section 5.1.10 (Ganot et al., 1999). The  experimental  setup  is  based on primer  extension. Ψ  residues  are  covalently coupled  to  the  compound  CMC  (see  section  5.1.10.1;  Figure  29C);  the  resulting adduct  poses  an  obstacle  to  reverse  transcriptase,  causing  stuttering  of  the transcribing enzyme (Denman et al., 1988). Similarly,  in the presence of very low nucleotide  concentrations,  2´‐O‐methylations  constitute  a  conformational  barrier to the passage of reverse transcriptase (Maden et al., 1995; Figure 29B). Pausing of the  enzyme  can  be  seen  as  distinct  bands  on  a  sequencing  gel.  As  a  proof  of principle,  I  tried  to  map  two  known  2´‐O‐methylation  sites  in  yeast  25S  rRNA (Figure  29D)  and  known  Ψ  sites  yeast  U2  snRNA  (Massenet  et  al.,  1999). Subsequently,  I wanted  to extend  the analysis  to  the E3 element of ASH1 mRNA, where both Puf6 and Loc1 have been shown to bind (Figure 4; Figure 29E).  Preliminary results are shown in Figure 30. While the visualization of Ψ residues did not work (data not shown), probably due to the low abundance of U2 snRNA in the  total  RNA  preparation,  the  two  2´‐O‐methylated  cytosines  at  positions  1437 and 1451 of  the 25S rRNA region were clearly  identified  (Figure 30A). However, mapping of putative 2´‐O‐methylated ribose molecules or pseudouridines was not 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possible  for  the  examined  region  of  ASH1,  though  the  ORF  had  been  highly overexpressed by a two‐hour galactose induction (Figure 30B).   
 









































1301  AAAATGGATG GCGCTCAAGC GTGTTACCTA TACTCTACCG TCAGGGTTGA
1351  TATGATGCCC TGACGAGTAG GCAGGCGTGG AGGTCAGTGA CGAAGCCTAG
1401  ACCGTAAGGT CGGGTCGAAC GGCCTCTAGT GCAGATCTTG GTGGTAGTAG
1451  CAAATATTCA AATGAGAACT TTGAAGACTG AAGTGGGGAA AGGTTCCACG
    1701  CAACTGCGAA ATTGAAGGGT ACCGTTGCTT ATTTTGTAAT TACATAACTG
    1751  AGACAGTAGA GAATTGATAC ATGGATAACT GAATCTCTTT CAACTAATAA
    1801  GAGACATTAT CACGAAACAA TTGTACATTT CTCTCCTTGT CTGTGCTAAA





(continued: Figure 29) C   Schematic  view  of  CMC  treatment  to  detect  pseudouridines.  Purified  RNA  is  incubated with CMC, which binds to the imino‐groups of e.g. uracil (U) and pseudouridine (Ψ), respectively. While the CMC‐U intermediate and one of the CMCs bound to Ψ are cleaved under alkaline conditions, the second  CMC  bound  to  Ψ  is  stable  (Bakin  &  Ofengand,  1993).  B  and  C  adapted  from  Bakin  & Ofengand, 1993. D  Genomic DNA sequence (nucleotides 1301 to 1500) of RDN25­1 encoding 25S rRNA (Johnston et  al.,  1997).  The  oligonucleotide  used  for  primer  extension  is  indicated  in  cyan  (reverse complement), 2´‐O‐methylated nucleotides in red (Ganot et al., 1999). E  Genomic DNA sequence of a part of the ASH1 ORF (nucleotides 1701 to 1767) and 133 nt of the 3´‐UTR (Dujon et al., 1994). The E3  localization element  is  shown  in black,  flanking sequences  in grey,  the  oligonucleotide  used  for  primer  extension  in  cyan  (reverse  complement),  and  possible Puf6 binding sites (see Gu et al., 2004) in green.  To  summarize,  an  experimental  setup  based  on  primer  extension  with fluorescently  labeled  primers  to map  post‐transcriptional modifications  of  RNAs works  in principle, but  there are  some  technical problems  to overcome before  it can be applied on ASH1 mRNA. 











































































Figure 30   Primer extension experiments allow detection of 2´-O-methylated nculeotides 
in 25S rRNA, but not in ASH1 mRNA. A  Primer extension experiment to detect 2´‐O‐Me and Ψ modifications in a region of 25S rRNA. The sequence  is assigned  from nucleotides C1400  to T1452;  in  the  lower part of  the gel, blue circles indicate individual base signals. While no pseudouridylations are detectable, the two known 2´‐O‐methylations  C1437  and  C1451  (red  triangles)  can  be  detected  (see  Ganot  et  al.,  1999).  Primer extension  sequences  are  reverse  complement,  therefore  Cs  appear  as  Gs  and  are  indicated accordingly in the figure (see Figure 29). B  Primer extension experiment of a region of ASH1 mRNA containing the E3 element. Although 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ASH1  mRNA  (Jansen  et  al.,  1996;  Long  et  al.,  1997),  further  trans‐acting  factors have  been  characterized,  among  them  Loc1  and  Puf6.  Both  proteins  have  been shown to be mainly present in the nucleus, in contrast to other localization factors (Gu et al., 2004; Long et al., 2001). Microscopic data in the present study indicate that Loc1 and Puf6 are predominantly confined to a subnuclear compartment, the nucleolus.  This  result  is  in  agreement  with  a  genome‐wide  analysis  of  protein localization  using  GFP‐fusions  (Huh  et  al.,  2003),  and  with  data  from  an independent study focusing on Loc1 (Urbinati et al., 2006).  To  date,  more  than  30  mRNAs  in  yeast  have  been  shown  to  localize  at  least partially to the bud tip in a She‐dependent manner (see Table 1). However, most of our knowledge on the function of trans‐acting factors other than She proteins, such as Khd1, Loc1, or Puf6, derives  from analysis of only one  localizing mRNA, ASH1 (Gu et al., 2004; Irie et al., 2002; Long et al., 2001). In part, this can be explained by historical reasons, since ASH1 was the first localized mRNA identified in yeast and consequently is also characterized best. Correct delivery of ASH1 mRNA and tight translational  regulation  are  indispensable  to  achieve mating  type  switching  and thus formation of diploid a/α cells.  In contrast, RNA asymmetry seems to be  less important  for  other  targeted  transcripts  (Shepard  et  al.,  2003)  and  invokes  the question  whether  they  require  regulation  to  a  similar  extent  as  ASH1.  In  a comparative analysis of deletions of four predominantly nucleolar proteins (Mrt4, Nop16, Loc1,  and Puf6,  the  latter  two being established ASH1 mRNA  localization factors)  I  found  that  Loc1  has  by  far  the  greatest  impact  on  ASH1  targeting. Therefore, I used a complete deletion of LOC1 to analyze the effect on localization of  two more mRNAs,  IST2  and WSC2,  which  differ  from ASH1  in  their  cell  cycle regulation.  Furthermore,  the  respective  proteins  Ist2  and  Wsc2  are  integral membrane proteins, and Ist2 distribution is not restricted to buds (Jüschke et al., 2004). 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Due to experimental limitations it was more difficult to detect bud tip localization of  these mRNAs even  in wild  type cells despite  the use of strains carrying a high copy  number  plasmid  with  the  ORF  of  interest.  This  is  a  result  of  the  different probes that were used for FISH of IST2 and WSC2 mRNA: While the directly labeled oligonucleotides used for ASH1 visualization contain an exactly defined number of fluorescent  labels  per  probe  and  display  a  high  signal/noise  ratio,  digoxigenin‐labeling  by  in  vitro  transcription  is  never  complete,  and  the  relative  number  of labels per probe is lower. Despite this experimental limitation, I detected a strong increase of small‐budded cells with delocalized WSC2 mRNA from ≈35% to ≈75% upon deletion of LOC1. For 
IST2 mRNA, the effect was much less prominent, but still statistically significant.  Recent work  has  proven  that  Khd1  and  Puf6  participate  in  localization  of more than one mRNA. Similar to Δloc1 cells, IST2 mRNA delocalizes in Δpuf6 cells (Deng et  al.,  2008).  For Khd1, on  the other hand, binding  sites  in  the  coding  regions of bud‐tip localized mRNAs like MID2, MTL1 (for Mid2‐like; Rajavel et al., 1999), and 
WSC2 mRNA have been mapped. MTL1 mRNA and Mtl1 protein  levels have been shown to increase upon overexpression of Khd1 (Hasegawa et al., 2008). In conclusion, ASH1 mRNA localization factors Khd1, Puf6, and now also Loc1 are involved  in  targeting  of  additional mRNAs,  arguing  against  the  notion  that ASH1 mRNA  localization  is  an  exception  in  terms  of  regulation  and  number  of  trans‐acting  factors.  Whether  the  involvement  of  the  mentioned  factors  applies  to  all localized mRNAs or only to a specific subset remains to be determined.  
3.2. The nucleolus is a site of ribonucleoprotein maturation The  so‐called  nuclear  history  is  essential  for  correct  assembly  and  transport  of RNPs in a variety of eukaryotic cells. Examples comprise Vg1 and VegT in Xenopus oocytes,  oskar  in Drosophila  oocytes  and  β­actin  in  vertebrate  cells  (see  section 1.5).  In  addition,  Fragile  X  mental  retardation  protein  (FMRP),  a  RNA‐binding protein  suggested  to  participate  in  localization  of mRNAs  to  dendrites,  has  been shown  to accumulate  in nuclei or  subnuclear  structures  if nuclear RNA export  is blocked  by  siRNA‐knockdown  of  Tap/NXF1,  the  mammalian  homolog  of  Mex67 (Kim et al., 2009). FMRP is encoded by the FMR1 gene, whose mutation is the cause for  fragile  X mental  retardation  syndrome,  an  inherited  disease  associated  with defective mRNA  transport  (for  review,  see Dahm & Macchi, 2007 and  references 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therein).  Whether  the  observed  subnuclear  structures  correspond  to  nucleoli remains  to  be  determined.  Interestingly,  nucleolar  accumulation  upon  block  of nuclear  export  has  already  been  shown  for  another  mammalian  RNA‐binding protein, Staufen2 (Macchi et al., 2004; see section 3.2.3). The  finding  that  two  predominantly  nucleolar  proteins  affect  mRNA  targeting, together with other results of this thesis and several previously published studies, suggests that the nucleolus is involved in translational regulation and localization of  mRNAs.  For  a  long  time,  the  nucleolus  has  been  seen  mainly  as  a  ribosome factory (Olson et al., 2000). However, it is now well established that the nucleolus contributes  to  various  cellular  processes,  including  cell  cycle  regulation,  stress responses and formation of multiple RNPs in addition to ribosome formation (for review, see Boisvert et al., 2007). First indications for a role of the nucleolus for the export  of  RNAs  to  the  cytoplasm  came  from  irradiation  experiments  with heterokarya (Sidebottom & Harris, 1969). The following examples shall provide a basis  for  the  model  of  nucleolar  function  in  yeast  mRNA  localization  presented below.  
3.2.1. Signal recognition particle (SRP) The signal recognition particle (SRP), a complex of six proteins and one RNA (7S SRP‐RNA;  scR1  in  yeast)  that  binds  to  ribosomes  translating  secretory  proteins and accompanies them to the endoplasmic reticulum (Halic & Beckmann, 2005), is assembled  inside the nucleolus. For yeast  it has been demonstrated that  the  four core  SRP  proteins  (Srp14,  Srp21,  Srp68,  and  Srp72)  enter  the  nucleolus independently from one another via a Ran‐dependent ribosomal protein transport route. Subsequent assembly with scR1 yields a pre‐SRP, which leaves the nucleolus and, after addition of a further protein component (Sec65), the nucleus (Grosshans et al., 2001).  If scR1  is processed aberrantly at  the 3´‐end or cells  lack any of  the core proteins, the RNA is trapped inside the nucleolus,  indicating that  incorrectly assembled pre‐SRP are not export‐competent (Grosshans et al., 2001). Intriguingly, mammalian  SRP‐RNA  accumulates  in  intranucleolar  regions  where  protein  and RNA markers  for  ribosome biogenesis  are  less  concentrated  (Politz  et  al.,  2002). This ultimately  led  to  the proposal of a nonribosomal  landscape  in  the nucleolus with functions distinct from ribosome biogenesis (Politz et al., 2005). 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3.2.2. The nucleolus and viral infection Nucleolar targeting is also a common phenomenon observed for a variety of viral proteins (see Hiscox, 2007 for review). For example, the herpesvirus saimiri (HVS) RNA‐binding ORF57 protein, which  is  important  for cytoplasmic accumulation of virus mRNA,  localizes  to  the nucleolus of  infected cells, where  it  colocalizes with components of the mRNA export machinery that are redistributed to the nucleolus during infection. If nucleolar entry of the ORF57 protein is impeded by deletion of its  nucleolar  localization  sequence  (NoLS),  the  intronless  viral  mRNA  cannot  be exported  from the nucleus,  though  it  still  can  interact with both mRNA and RNA export  factors  (Boyne & Whitehouse,  2006).  Similarly,  nucleolar  exclusion of  the groundnut  rosette  virus  (GRV;  a  plant  RNA  virus)  ORF3  protein  abolishes formation of cytoplasmic RNPs and long distance movement through the phloem, which  is  a  prerequisite  for  systemic  infection  (Kim  et  al.,  2007).  Interestingly, ORF3  protein  is  probably  redistributed  to  the  cytoplasm  along  with  a subpopulation of the predominantly nucleolar protein fibrillarin, which also seems to be involved in viral RNP formation (Kim et al., 2007). Finally, correct function of human  immunodeficiency  virus  type  1  (HIV‐1)  proteins  Tat  and  Rev  requires nucleolar  localization, and since  the HIV‐1 RNA could also  traverse  the nucleolus as  part  of  an  export  strategy,  it  has  been  speculated  that  assembly  of  an  RNP containing  HIV‐1  RNA might  at  least  start  there  (Hiscox,  2007;  Michienzi  et  al., 2000). 
3.2.3. The nucleolus and cytoplasmic mRNA localization In addition  to viral RNPs and non‐mRNA‐containing RNPs,  there  is data pointing towards a  functional  relevance of nucleolar  transit  for some mRNPs as well.  In a seminal study with different cell lines, the transcripts of c­myc, N­myc and myoD1 were found to be enriched in nucleoli, while γ‐actin mRNA was not (Bond & Wold, 1993). More  recently,  the mammalian  brain‐specific  62  kDa  isoform  of  Staufen2 (Stau262),  a  double‐stranded  RNA  (dsRNA)  binding  protein,  has  been  shown  to accumulate in nucleoli in certain conditions (Macchi et al., 2004). Staufen has first been discovered as a localization factor for the maternal mRNAs oskar and bicoid in Drosophila, but meanwhile two mammalian homologs have been identified (for review,  see  Miki  et  al.,  2005).  Both  homologs  are  nucleocytoplasmic  shuttling proteins.  They  associate  with  distinct  but  overlapping  subsets  of  mRNAs  and 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participate in mRNA transport along microtubules in neurons (Furic et al., 2008). Prevalent nucleolar  localization of Stau262 fused to YFP was observed if  the third RNA‐binding domain (RBD3) was mutated so that the protein failed to bind RNA or if  exportin‐5  (Exp‐5),  which  is  involved  in  dsRNA  export,  was  downregulated (Macchi  et  al.,  2004).  Yet,  direct  binding  of  Stau2  to  a  specific mRNA  as well  as nucleolar  transit  of  any  putatively  bound  mRNA  has  not  been  proven  so  far. Therefore, a physiological significance of Stau2 nucleolar enrichment is elusive to date (Jellbauer & Jansen, 2008; Kiebler et al., 2005). In yeast, several findings suggest a participation of the nucleolus in mRNA export. Experiments with temperature‐sensitive conditional mutants of genes involved in RNA metabolism, such as RPA190 (for RNA polymerase A, the largest subunit of Pol I)  and  the  MTR  genes  (for  mRNA  transport  defective),  revealed  nucleolar accumulation of poly(A)+ RNA upon heat shock (Kadowaki et al., 1994; Kadowaki et al., 1995; Schneiter et al., 1995). A caveat in these studies is that the nucleolus disassembles during  the  long heat shock conditions used (≥2 h at 37°C or 42°C), making it difficult to monitor nucleolar accumulation of proteins (Liu et al., 1996). Furthermore, poly(A)+ RNA is very heterogeneous, and recent findings suggest that a nucleolar poly(A) domain in Δrrp6 cells contains snoRNAs and not mRNAs. Thus, it  seems  that  the  results  mentioned  above  and  of  a  similar  study  in 
Schizosaccharomyces pombe (Ideue et al., 2004) are inconclusive.  First data on nucleolar accumulation specific transcripts in yeast were obtained by a live imaging approach using the U1A‐GFP system (Brodsky & Silver, 2000). When the  3´‐UTR  of  ASH1  was  fused  to  the  3´‐end  of  a  construct  containing  16  U1A hairpin  loops and the PGK1 ORF (for 3‐phosphoglycerate kinase; Lam & Marmur, 1977),  the  GFP  signal  accumulated  in  nucleoli  at  nonpermissive  temperature  in three  conditional  mRNA  export  factor  mutants,  including  mex67­5.  A  similar accumulation was observed if PGK1 was replaced by another ORF, SSA4 (for stress 70 subfamily A,  a gene encoding a heat  shock protein; Werner‐Washburne et al., 1987),  but  not  if  the  ASH1  3´‐UTR  was  exchanged  for  the  endogenous  3´‐UTRs (Brodsky & Silver, 2000). Work  on  mRNAs  encoding  heat  shock  genes  SSA4  and  HSP104  (for  heat  shock protein)  revealed  that  these  transcripts  accumulate  at  the  site  of  transcription upon  block  of  nuclear  mRNA  export  (Jensen  et  al.,  2001).  Interestingly,  they localize to the nucleolus analogous to ASH1 mRNA if the experiment is performed 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in  cells  lacking  the  nuclear  exosome  component  RRP6  (Thomsen  et  al.,  2003; Figure  17L‐N).  Two  hypotheses  have  been  formulated  to  explain  these observations. First, the nucleolus with its high local concentration of RNA‐binding proteins might simply  be  a  reservoir  for  surplus  RNAs.  To  date,  it  remains  an  unresolved  issue why  heat  shock  mRNAs  accumulate  in  the  nucleolus  under  the  conditions described  and  there  is  no  evidence  indicating  a  precise  function  for  this accumulation (Torben Heick Jensen, personal communication). On the other hand, poly(A)+  RNA  localizes  to  the  nuclear  periphery  and  not  to  the  nucleolus  when RNA  export  is  blocked  and  RRP6  is  deleted  (Thomsen  et  al.,  2003),  suggesting some discrimination between different RNA populations.  Second,  it  is  conceivable  that  heat  shock  mRNAs  and  possibly  other  specific transcripts require nucleolar transit as part of their default exit route (Thomsen et al., 2003). Our observations with ASH1 mRNA argue in favor of this hypothesis. Not only  does  the  RNA  accumulate  in  the  nucleolus  in  a  mex67­5  Δrrp6  strain  at nonpermissive  temperature,  but  also one of  its main binding partners,  She2. We could even show that ASH1 FISH signals are not detectable in the nucleolus when She2  is  deleted  in  a  Δrrp6  strain,  suggesting  that  the  protein  is  required  for nucleolar accumulation of ASH1 (Du et al., 2008). Moreover, She2 is trapped in the nucleolus similar to Stau2‐RBD3 point mutants  if  it cannot bind to RNA, which  is the case for the RNA‐binding mutant She2(N36S, R63K) (Du et al., 2008; Gonsalvez et  al.,  2003).  This,  together  with  the  finding  that  for  instance  Khd1  does  not accumulate in nucleoli in mex67­5 cells at 37°C implies that nucleolar shuttling of She2  is  specific  and not a mere consequence of high RNA‐binding affinity, which would lead the protein to a compartment with elevated RNA concentrations (Du et al., 2008). The nucleolus also accommodates the localization factors Loc1 and Puf6, which  have  recently  been  shown  to  interact  in  vivo  with  She2  and ASH1  mRNA (Shen et al., 2009). 
3.2.4. A model of nucleolar function in mRNA localization At  present,  it  cannot  be  completely  ruled  out  that  nucleolar  localization  of  She2 and ASH1 does not occur under physiological conditions, because we have no tool in  hand  to  monitor  their  probably  very  fast  transit.  However,  with  the identification of a NLS in She2 and the finding that She2 is actively imported into 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the nucleus depending on the importin α Srp1 (for suppressor of rpb1; SGDproject, March  2009),  it  is  beyond  doubt  that  at  least  the  nucleus  plays  a  role  in  ASH1 mRNP formation (Du et al., 2008; Shen et al., 2009). Most likely, this role involves proper translational silencing, since exclusion of She2 from the nucleus, either by fusing  it  to  She3N  or  by mutating  the NLS  causes  defective  distribution  of  Ash1 protein, but has little effect on ASH1 mRNA localization (Figure 18; Figure 21; Shen et  al.,  2009).  ASH1  mRNA  distribution  is  not  affected  at  all  in  the  She3N‐She2 mutant  (Du  et  al.,  2008),  while  point  mutations  in  the  NLS  (mutant  She2‐M5A, Shen et al., 2009) apparently led to diminished anchoring of the mRNA. Still, about 90% of ASH1 mRNA  in She2‐M5A  localizes  to  the bud. Ash1 protein distribution has not been quantified in this mutant, but assuming a rate similar to She3N‐She2 (Figure  18),  the  10%  delocalized  transcript  can  hardly  explain  symmetric  Ash1 distribution in 50% of cells.  The  specification  that  the  nucleolus  has  a  significant  share  in  nuclear  steps  of mRNP  formation  seems  probable  if  we  take  the  following  results  into  account. First, She2 co‐immunoprecipitates with both Loc1 and Puf6, suggesting an in vivo interaction (Gu et al., 2004; Shen et al., 2009). Second, ASH1 mRNA interacts with Loc1 and Puf6  in vivo,  and  this  interaction depends on nuclear She2  (Shen et al., 2009). This has been a  longstanding question I had tried to tackle unsuccessfully with immunoprecipitation experiments followed by reverse transcription PCR (IP‐RT, data not shown). I speculated that the time‐frame is too narrow to detect the interaction,  and  consistently  successful  detection  required  cross‐linking  RNPs before  immunoprecipitation  (Shen  et  al.,  2009).  Third,  She2  accumulates  in  the nucleolus if it cannot bind RNA (Du et al., 2008). It is currently unknown how She2 is involved in recruitment of Loc1 and Puf6 to ASH1, but since it does not leave the nucleolus  without  the  RNA,  it  seems  more  likely  that  it  brings  the  RNA  to  the nucleolus than that it brings the protein factors to the RNA in the nucleoplasm.     Taken  together,  the  data  presented  above  allow  drawing  a  first  model  for  a nucleolar  step  in  the  formation  of  localizing  mRNPs  with  the  example  of  ASH1 mRNP, but the model might be applicable to other targeted mRNPs as well (Figure 32).  Pol  II  transcription  provides  primary  transcripts  in  the  nucleoplasm, which can in principle freely diffuse through the entire nucleus  including proteinaceous subnuclear compartments (Gorski et al., 2006). She2 is actively imported into the 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nucleus  and  binds  to  the  transcript. Whether  this  binding  occurs  already  in  the nucleoplasm or in the nucleolus is unclear at the moment, since RNA binding is not a prerequisite  for nucleolar  entry of  She2  (Du et  al.,  2008).  Inside  the nucleolus, the  translational  repressor  Puf6  is  loaded  onto  the  pre‐mRNP.  This  step  might require a loading helper to displace She2 from the blocked Puf6 binding site (see Figure 4) or to change the conformation of the mRNA to increase affinity for Puf6.  
 











































diffuse back to the nucleoplasm. There, additional translational control is obtained by recruitment of Khd1, and the mRNP is exported from the nucleus. Once in the cytoplasm, She2 binds to She3, and the complex is transported to the bud tip in a myosin‐dependent  fashion  along  actin  cables.  At  the  destination,  translational repressors Puf6  and Khd1 are phosphorylated,  and  translation of  the mRNA can start. 
3.2.5. Implications of a nucleolar role in mRNP formation Could the presented model be valid for other localizing RNPs as well? It has been demonstrated that another cellular RNA‐binding protein, Stau262, can accumulate in  nucleoli  as  well  (Macchi  et  al.,  2004).  Similarly,  several  viral  RNA‐binding proteins  such  as HIV‐1 Rev,  HVS ORF57  protein,  and GRV ORF3  protein  require transient  nucleolar  localization  for  proper  function  in  viral  RNA  export  or  RNP assembly  (Boyne  &  Whitehouse,  2006;  Dundr  et  al.,  1995;  Kim  et  al.,  2007). Furthermore,  GRV  ORF3  even  helps  to  integrate  the mainly  nucleolar  fibrillarin into functional RNPs (Kim et al., 2007), a finding reminiscent of the incorporation of  Puf6  into  the ASH1 mRNP.  Thus,  occurrence  of  functional  nucleolar  transit  in RNP biogenesis aside from the ASH1 mRNP appears conceivable. A  second  question  that  arises  from  the  model  presented  is  what  possible advantage cells might gain from a nucleolar step in mRNP assembly. One obvious explanation is certainly economic use of resources. If a subset of mRNPs needs to be remodeled,  they could simply be directed to  the site where a  large number of enzymes  required  to  process  and  remodel  precursors  of  ribosomes,  the  most abundant cellular RNPs, resides anyway (see section 1.2). The fact that for instance snRNP and SRP assembly steps occur in the nucleolus corroborates this view (see section 3.2.1; Gerbi et al., 2003).  Moreover, there are initial results that not only ribosomal RNAs, but also snRNAs and  even  mRNAs  may  be  modified  through  2´‐O‐ribose‐methylation  and pseudouridylation  (reviewed  in  Decatur  &  Fournier,  2003).  When  the  technical problems described (section 2.9.1) will be solved, also ASH1 mRNA can be tested for  the  presence  of  such  modifications.  In  general,  modification  of  mRNAs  may represent a possibility to distinguish between different sets of RNPs,  for example localizing and non‐localizing mRNPs. Besides, methylation or pseudouridylation of nucleotides  might  contribute  to  translational  control,  acting  as  molecular  speed 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bumps to slow down scanning ribosomes. Consequently, modifications are likely to be found in the non‐translated regions of mRNAs, for example the 5´‐UTR or the 3´‐UTR; in trypanosomes, a Ψ residue has indeed been identified in the spliced leader (SL), a small RNA transferred to the 5´‐end of pre‐mRNAs 30 – 100 nt upstream of the Start codon (Jäger et al., 2007; Liang et al., 2002). Finally,  transit  of  mRNPs  through  the  nucleolus  could  furnish  a  quality  control step.  For  instance,  it  has  been  speculated  that  so‐called  specialized  ribosomes containing  a  specific  subset  of  ribosomal  proteins,  are  necessary  for  controlled translation of ASH1 mRNA, and that Loc1 is involved in their biogenesis (Komili et al.,  2007).  Although  it  remains  completely  obscure  how  these  specialized ribosomes  can  be  assembled,  their  precursors  might  somehow  prime  localizing mRNPs. On the other hand, lack of any translational activity renders the nucleolus a well‐suited environment to initiate translational silencing. mRNPs that fail to be regulated  could  be  immediately  marked  for  degradation,  e.g.  by  the  nuclear exosome and would not even  leave the nucleus.  Interestingly, such a process has already  been  shown  for  defective,  nuclear‐restricted  pre‐60S  subunits:  rRNA precursors are polyadenylated, and the pre‐ribosomes,  together with  the nuclear exosome  and  the  TRAMP  complex  (for  Trf4/Air/Mtr4  polyadenylation), accumulate in a subnucleolar region termed the No‐body (Dez et al., 2006). 
3.3. Loc1 and Puf6 contribute to biogenesis of 60S ribosomal subunits Characterization  of  Loc1  and  Puf6  in  the  course  of  this  study  and  by  others  has revealed  a  role  for  both  proteins  in  ribosome  biogenesis  (Figure  14;  Figure  15; Figure 16; Harnpicharnchai et al., 2001; Urbinati et al., 2006). Both Loc1 and Puf6 co‐purify with a  large complex that only disassembles at high salt concentrations (Figure 9). With the help of mass spectrometry I was able to  identify two known interactors  of  Puf6  (Table  2).  The  overall  band  pattern  is  consistent  with  other purifications of 60S subunit biogenesis factors such as Cic1, Nog1, Nop7 and Rlp24 (Harnpicharnchai  et  al.,  2001;  Nissan  et  al.,  2002;  Saveanu  et  al.,  2003).  Indeed, purifications with  the mentioned  proteins  as  bait  –  either  in  studies  focused  on individual  proteins  (see  above)  or  in  a  systematic  analysis  (Gavin  et  al.,  2006)  – identified Loc1 and Puf6 as members of the respective complexes. I concluded that the  large  number  of  bands  with  an  apparent  molecular  weight  below  50  kDa corresponded to ribosomal proteins of the large subunit, as identified in the Loc1 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and Puf6 purifications of the high throughput study (Gavin et al., 2006). A control purification of Hpr1,  a nuclear protein  implicated  in mRNA export, did not  show this  band  pattern  after  the  second  purification  step  (Figure  9B).  At  standard purification conditions, it was very difficult to see the band corresponding to Loc1, possibly due to the low concentration of just 3650 molecules per cell (Puf6: 21500 molecules/cell;  Ghaemmaghami  et  al.,  2003).  Purification  under  high  salt conditions showed a distinct band below 30 kDa  that corresponded to Loc1, and this band is also visible in standard purifications (Figure 9B). In contrast to immunoprecipitations from other groups, I have never identified an interaction between She2 and Puf6 or Loc1 in TAP (Figure 9C and data not shown). I speculated that the pre‐60S particle I purified when using Puf6 or Loc1 as bait is rather  stable,  while  interaction  of  nucleolar  She2 with  Puf6  and  Loc1 would  be only  transient.  Consequently,  use  of  She2  as  bait  purifies  mainly  cytoplasmic interactors such as Myo4 (Gavin et al., 2006).  A more direct assay to investigate the role of Loc1 and Puf6 in ribosome biogenesis is  sucrose  density  gradient  centrifugation  of  total  RNA  from  strains  carrying knockouts of LOC1 and PUF6, respectively (Rotenberg et al., 1988). Consistent with the TAP  results,  polysome profiles  of Δloc1  and,  to  a  smaller  extent, Δpuf6  cells, were  characteristic  for  defective  large  subunit  (LSU)  biogenesis  and  greatly differed  from  profiles  of  cells  where  a  40S  factor  had  been  deleted  (Figure  14; Adams  et  al.,  2002  and  references  therein).  The  observed  halfmers  result  most likely from defective LSU biogenesis and not from a block in translation initiation (Rotenberg  et  al.,  1988),  since  the  60S  peak  is  also  reduced.  The  effects  on  60S subunit maturation are a direct consequence of protein depletion and not caused indirectly by slow growth,  since a Δpuf6 strain grows at wild‐type  levels even at 37°C  (Figure 24),  and Loc1 depletion  leads  to  the described defects  in  ribosome biogenesis  long  before  cell  growth  is  affected  (Figure  28).  For  Loc1,  polysome profiles at conditions that disrupt ribosomes into subunits confirmed that the total number  of  ribosomal  subunits  is  reduced  in Δloc1  cells,  and  that  the  amount  of large subunits decreases disproportionately to small subunits (Figure 16). Finally, detailed analysis of newly synthesized rRNA intermediates by in vivo pulse labeling  (Ferreira‐Cerca  et  al.,  2005)  further  clarified  where  in  large  subunit assembly Loc1 and Puf6 possibly act. Again, only a weak phenotype was detected 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3.4. Loc1 might contribute to remodeling of mRNAs in the nucleolus Besides  affecting  biogenesis  of  the  large  ribosomal  subunit,  disruption  of  LOC1 compromises  localization  of  ASH1  mRNA  and  asymmetric  distribution  of  Ash1 protein.  In  the  present  thesis,  I  provide  evidence  that  Loc1  function  in  these pathways may be  coupled.  First,  truncation  analysis  of  the protein did not  show that different parts of the protein are specifically required for one process (Figure 23).  Second,  rapid  depletion  of  Loc1  by  glucose  shut‐off  led  to  concomitant impairment of both processes already at one hour post‐shift, arguing against a first response  in  ribosome  biogenesis  with  a  subsequent  indirect  effect  on  RNA localization due to reduced levels in 60S subunits (Figure 28). Functional  coupling  in  the  present  context  signifies  that  Loc1  is  involved  in analogous  reactions  relevant  for  mRNA  localization  as  well  as  for  ribosomal subunit maturation.  The main  question  arising  from  this  definition  is  how  these reactions  look  like  on  a molecular  level  or,  in  simple words, what  the molecular function of Loc1 could be.  So  far,  technical  problems  have  prevented my  analysis  of modifications  in RNAs other  than  rRNAs  (see  section  2.9.1).  Since  cells  survive  without  Loc1,  a  direct involvement  in  methylation  or  pseudouridylation  of  RNAs  does  not  seem  very likely.  However,  physical  interaction  with  Gar1  (for  glycine  and  arginine  rich domain protein; Bousquet‐Antonelli et al., 1997), a core protein of H/ACA snoRNPs responsible  for Ψ  formation,  has  recently  been  reported  (Tarassov  et  al.,  2008). Puf6  also  interacts  physically  with  core  components  of  H/ACA  snoRNPs  (Cbf5, Gar1) as well as with C/D snoRNPs (Nop1) (Collins et al., 2007; Gavin et al., 2006; Gavin et al., 2002; Krogan et al., 2006). It is therefore possible that Loc1 and Puf6 help to recruit RNA modifying complexes to pre‐ribosomal particles and perhaps also pre‐mRNPs, though it cannot be excluded that physical interaction in this case just implies to belong to the same huge complex, the pre‐60S particle. The second hypothesis on the molecular function of Loc1 is, as mentioned above, that it might act in folding of RNAs. Interestingly, most proteins with assigned RNA chaperone activity are multifunctional and cause pleiotropic effects when mutated (Schroeder  et  al.,  2004).  Moreover,  nucleic  acid  chaperone  function  has  already 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been reported  for a protein  implicated  in mRNA localization, FMRP (Gabus et al., 2004). Lack of a positive control has so far impeded to test Loc1 in an in vivo RNA chaperone assay, but this difficulty should be resolvable in the near future. Despite a  missing  direct  proof,  some  findings  suggest  that  the  presented  hypothesis  is reasonable.  First  of  all,  I  have  found  a  synthetic  sickness  phenotype  in  a  double deletion of LOC1 and LHP1 (section 2.9.2), the yeast homolog of La, as well as in a double  deletion  of  LOC1  and  LSM7  (data  not  shown).  Both  genetic  interactions have  meanwhile  been  confirmed  by  high‐throughput  analysis  (Wilmes  et  al., 2008). La and Sm‐like proteins stabilize noncoding RNAs and supposedly modulate RNA structure (Wolin & Wurtmann, 2006). Genetic interaction of Loc1 with La and a nuclear Lsm protein may be plausibly explained with a redundant function in the same pathway, in this case RNA folding.  The  amino  acid  sequence  and  predicted  secondary  structure  of  Loc1  (Figure  7) hint  to  a  function  in  RNA  folding  as  well.  Loc1  shows  several  properties  of  a natively disordered protein (Fink, 2005), e.g. a high level of disorganized structure, especially  in  the  central  third,  as  indicated  by  prediction  of  secondary  structure and intrinsic protein disorder (DisEMBL™; Linding et al., 2003). In addition, Loc1 has a high net charge (isoelectric point pI=11.1; SGDproject,   March 2009), and a high level of disorder‐promoting amino acids such as glutamic acid (E), lysine (K), and arginine (R), which alone account  for almost 40% of Loc1 primary sequence (Figure  7).  Despite  widespread  occurrence  of  natively  disordered  regions  in cellular  proteins,  especially  in  the  nucleolus,  it  is  interesting  to  note  that  the highest frequency of disorganized structure of all protein classes is found in RNA chaperones, and it appears that these unstructured regions are critical for function (Fink, 2005). Disordered segments allow keeping the protein surface small, while allowing  a  substantially  larger  interface  for  interaction  with  substrates  as compared  to  ordered  segments.  Importantly,  disordered  segments  also  furnish structural  plasticity,  permitting  recognition  of  different  targets  with contemporaneous  maintenance  of  specificity  (Emmott  &  Hiscox,  2009; Gunasekaran et al., 2003). If we apply these general findings to the particular case of Loc1, it is evident that the  most  probably  natively  unfolded  central  region  allows  binding  to  multiple target RNAs, comprising localizing mRNAs as well as pre‐rRNA. On the other hand, the  N‐  and  C‐terminal  parts  of  the  protein,  which  show  a  higher  degree  of 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predicted  secondary  structure, might  be  dispensable  for  function.  Consistently,  I find  that  truncation  of  these  parts  does  not  significantly  impair  Loc1  function (Figure 23).  In conclusion, a model  for the molecular  function of Loc1 could be formulated as follows  (Figure  33).  Loc1  binds  to  double‐stranded  RNAs  in  the  nucleolus. Specificity  for  localizing mRNAs  like ASH1,  IST2,  and WSC2  and  ribosomal  RNAs may be conferred by proteins interacting with the RNAs in vivo, such as She2, since Loc1 does not show specific binding to dsRNAs in vitro (Long et al., 2001). Binding to  substrates  triggers  partial  un‐  and  refolding,  favoring  loading  of  additional factors  to  distinct  motifs.  Even  displacement  of  previously  bound  factors  is conceivable. For example, Loc1 might displace She2 from the E3 LE of ASH1 mRNA; subsequent  refolding might  promote  binding  of  Puf6  to  E3  perhaps  as  part  of  a nucleolar “handover” process, similar to the nuclear handover proposed for of β‐actin  mRNA  from  ZBP2  to  ZBP1  (Pan  et  al.,  2007).  Finally,  Loc1  releases  the refolded RNAs. 
 








Name                  Supplier Avian Myeloblastosis Virus (AMV)  Reverse Transcriptase            Promega Calf Intestine Alkaline Phosphatase (CIAP)  Fermentas DNase‐free RNase              Roche  DNA Polymerase I, Large (Klenow) Fragment  New England BioLabs Herculase® II Fusion Enzyme        Stratagene Lysozme                 Sigma‐Aldrich Moloney Murine Leukemia Virus (M‐MuLV) Reverse Transcriptase            Fermentas Proteinase K                Roche Applied Science Restriction Endonucleases          Fermentas, New England BioLabs RNasin® Plus RNase Inhibitor        Promega RQ1 RNase‐free DNase           Promega SUPERase⋅In™              Ambion T4 DNA Ligase              Fermentas T4 DNA polymerase            New England BioLabs T7 RNA Polymerase            Promega Taq Polymerase              Axon VentR® DNA Polymerase          New England BioLabs Zymolyase 20T              Seikagaku Corporation Zymolyase 100T              Seikagaku Corporation 
 
4.1.2. Antibiotics & Drugs 
Name                  Supplier Ampicillin (Amp)              Roth Chloramphenicol (Cla)            Sigma‐Aldrich Cycloheximide (CHX)            Sigma‐Aldrich Doxycycline (dox)              Sigma‐Aldrich Geneticin (G418)              Gentaur 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Kanamycin (Kan)              Sigma‐Aldrich Nourseothricin (clonNAT, nat)        Werner BioAgents Tetracycline (Tet)              Sigma‐Aldrich 
4.1.3. Special chemicals All standard laboratory chemicals were purchased from the centralized purchasing of the Gene Center. Special chemicals are listed below. 
Name                    Supplier 40% Acrylamide/Bisacrylamide (19:1) (fluorescence‐free)              Roth 
N‐cyclohexyl‐N´‐β‐(4‐methylmorpholinium)‐ ethylcarbodiimide p‐tosylate (CMC)        Fluka 4′,6‐Diamidino‐2‐phenylindole dihydrochloride (DAPI); in this study substituted by Hoechst Stain  solution                    Sigma‐Aldrich Diethylpyrocarbonate (DEPC)          Roth Isopropyl‐β‐D‐1‐thiogalactopyranoside (IPTG) Urea (fluorescence‐free)            Roth 
4.1.4. DNA, RNA & Size Standards 
Name                    Supplier Herring Sperm DNA              Sigma‐Aldrich Salmon sperm DNA, 10 mg/ml          Invitrogen Yeast genomic DNA, 10 mg/ml          Invitrogen O´GeneRuler™ DNA ladder mix          Fermentas RNA markers                 Promega 
4.1.5. Antibodies 
Name                      Source Mouse monoclonal anti‐Actin (clone C4)          Millipore Mouse monoclonal anti‐Fibrillarin (clone 28F2)        abcam Mouse monoclonal anti‐HA HA.11 (clone 16B12)        Covance Mouse monoclonal anti‐myc (clone 9E10)          IMP, Vienna Mouse monoclonal anti‐myc (clone 9E11)          IMP, Vienna Rat monoclonal anti‐Tubulin (clone 3H3087)         Santa Cruz Rat monoclonal anti‐HA high affinity (clone 3F10)        Roche Applied Science Rabbit polyclonal anti‐She2 (323/4, E12, #7)         Tung‐Gia Du AlexaFluor® 488 goat anti‐mouse IgG (H+L)           Molecular Probes 
Materials 
79 
AlexaFluor® 488 goat anti‐rabbit IgG (H+L)          Molecular Probes AlexaFluor® 488 goat anti‐rat IgG (H+L)          Molecular Probes AlexaFluor® 488 rabbit anti‐mouse IgG (H+L)        Molecular Probes AlexaFluor® 594 rabbit anti‐mouse IgG (H+L)        Molecular Probes polyclonal sheep anti‐Digoxigenin‐AP Fab fragments (anti‐DIG)  Roche Applied Science Peroxidase‐conjugated AffiniPure goat anti‐mouse IgG (H+L)    Jackson ImmunoResearch Peroxidase‐conjugated AffiniPure goat anti‐rat IgG (H+L)    Jackson ImmunoResearch Peroxidase‐conjugated AffiniPure goat anti‐rabbit IgG (H+L)    Jackson ImmunoResearch 
4.2. Strains 
4.2.1. Yeast strains 
Name  Essential Genotype            Origin RJY5    MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    Jansen et al., 1996 (K4452) 
trp1­1, ura3, HO­ADE2, HO­CAN1 RJY137  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112, trp1­1,  Bobola et al., 1996 (K5863) 
ura3, ASH1­myc9 RJY280  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    I. Gonzalez 
trp1­1, ura3, ash1::URA3, (2×) TRP1::GAL­ASH1­myc RJY358  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    n/a 
trp1­1, ura3, GAL, psi+ RJY359  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    n/a 
trp1­1, ura3, GAL, psi+ RJY1149  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112, trp1­1,  Segref et al., 1997 (mex67‐5) 
ura3­52, GAL+, mex67::HIS3, pUN100­LEU2­mex67­5 RJY1357  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    D. Ferring 
trp1­1, ura3, pRS426­IST2  RJY1462  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112, trp1­1,  n/a 
ura3, ASH1­myc9, she2::URA3 RJY2017  MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0,       EUROSCARF (Y04330) 





YCplac111­GFP­SHE2(N36S, R63K) RJY2799 MATa, can1Δ, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, lypΔ,    Tong et al., 2001 (BY5563)  
mfa1::MFA1pr­HIS3, cir+, gal2  RJY2810 MATa, can1Δ, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, lypΔ,    this study  
mfa1::MFA1pr­HIS3, cir+, gal2, puf6::natNT2 RJY2811  MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, loc1::HIS3MX6  this study RJY2819  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,     this study 
trp1­1, ura3, LOC1­CBP­TEV­ProtA::K.l.TRP1   RJY2820  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,     this study 





RJY2845 MATa, can1Δ, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, lypΔ,    this study  
mfa1::MFA1pr­HIS3, cir+, gal2, loc1::natNT2 RJY2881  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, GAL, psi+, puf6::natNT2 RJY2882  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, GAL, psi+, puf6::natNT2 RJY2894  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,     this study 
trp1­1, ura3, loxP­ProtA­TEV­CBP­LOC1 RJY2930  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, GAL, psi+, loc1::natNT2 RJY2931  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, GAL, psi+, loc1::natNT2 RJY2932  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112, trp1­1,  this study 
ura3 PUF6­CBP­TEV­ProtA::K.l.TRP1, she2::HIS3MX6  RJY2934  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,     this study 
trp1­1, ura3 PUF6­CBP­TEV­ProtA::K.l.TRP1,  
SHE2­myc9::HIS3MX6 RJY2935  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, mrt4::HIS3MX6 RJY2937  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, lsm7::HIS3MX6 RJY2943  MAT ? ade2­1, can1­100, his3­11,15, leu2­3,112,    Sträßer et al., 2002  
trp1­1, ura3­52, HPR1­CBP­TEV­ProtA::K.l.TRP1  RJY2964  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,     this study 
trp1­1, ura3 PUF6­CBP­TEV­ProtA::K.l.TRP1,  
loc1::HIS3MX6 RJY2965  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,     this study 
trp1­1, ura3 PUF6­CBP­TEV­ProtA::K.l.TRP1,  
LOC1­HA3::HIS3MX6  RJY2997  MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0,        this study 
YEplac195­ASH1 RJY3133  Mata, ade2­1, can1­100, his3­11,15,  leu2­3,112, trp1­1,  this study 
ura3, UBR1::GAL­HA­UBR1 (HIS3), 
LOC1::kanMX4­pCUP1­myc­td RJY3147  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, nop16::HIS3MX6 RJY3148  MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0,      this study 
nop16::HIS3MX6 RJY3150  Mata, ade2­1, can1­100, his3­11,15,  leu2­3,112, trp1­1,  this study 
ura3, UBR1::GAL­HA­UBR1 (HIS3), 
LOC1::kanMX4­pCUP1­myc­td, LOC1­HA6::natNT2 RJY3153  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, LOC1­HA6::natNT2 RJY3162  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study  
trp1­1, ura3, ash1::URA3, (2×) TRP1::GAL­ASH1­myc 
loc1::HIS3MX6 RJY3163  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study  
trp1­1, ura3, ash1::URA3, (2×) TRP1::GAL­ASH1­myc 
puf6::HIS3MX6 RJY3164  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study  
trp1­1, ura3, ash1::URA3, (2×) TRP1::GAL­ASH1­myc 
she2::HIS3MX6 RJY3188  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, LOC1­HA6::natNT2 RJY3189  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, 





RJY3191  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, 
LOC1(aa1­140)­HA6::natNT2 RJY3192  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, 
LOC1(aa1­72)­HA6::natNT2 RJY3200  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, loc1::natNT2 RJY3211  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, 
LOC1(aa1­115)­HA6::natNT2 RJY3221  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, 





ura3, ASH1­myc9, p416­GALS­LOC1­HA6 RJY3260  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, mrt4::HIS3MX6 RJY3261  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, puf6::HIS3MX6 RJY3262  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, khd1::HIS3MX6 RJY3264  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, nop16::HIS3MX6 RJY3265  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, she2::natNT2 RJY3269  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, ash1::URA3, (2×) TRP1::GAL­ASH1­myc 
she2::HIS3MX6, YCplac22­SHE3N­SHE2 RJY3272  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, arx1::natNT2 RJY3273  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, ltv1::HIS3MX6 RJY3274  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, nop6::HIS3MX6 RJY3275  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, rrp8::HIS3MX6 RJY3276  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HO­ADE2, HO­CAN1, ssf1::HIS3MX6 RJY3361  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, natNT2­pGALS­HA3­LOC1 RJY3362  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HIS3MX6­pGAL1­HA3­LOC1 RJY3419  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, mrt4::HIS3MX6, YEplac195­ASH1 RJY3453  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, ASH1­myc9, she2::URA3,  
YCplac22­SHE3N­SHE2 RJY3454  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, ASH1­myc9, she2::URA3,  




YCplac22­2×NLS­SHE3N­SHE2 RJY3463  MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0,      this study     YEplac195­ASH1 RJY3469  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, lhp1::HIS3MX6 RJY3470  MATa/a, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, GAL, psi+, LHP1/lhp1::HIS3MX6,  
LOC1/loc1::natNT2  RJY3478  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, lhp1::HIS3MX6, loc1::natNT2 RJY3479  MATα, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, lhp1::HIS3MX6, loc1::natNT2 RJY3501  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, pRS426­WSC2  RJY3502  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, GAL, psi+, loc1::natNT2, YEplac195­ASH1 RJY3503  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, loc1::natNT2, pRS426­IST2  RJY3504  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, loc1::natNT2, pRS426­WSC2  RJY3505  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, YEplac195­ASH1 RJY3506  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, GAL, psi+, LOC1­yeGFP::HIS3MX6 RJY3507  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, GAL, psi+, PUF6­yeGFP::HIS3MX6   RJY3511  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study 
trp1­1, ura3, HIS3MX6­pGAL1­HA3­LOC1, 
YEplac195­ASH1 RJY3514  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study  
trp1­1, ura3, HO­ADE2, HO­CAN1, PUF6­HA6::natNT2   RJY3520  MATa, ade2­1, can1­100, his3­11,15, leu2­3,112,    this study  
trp1­1, ura3, pRS426­pGAL1­ASH1   
4.2.2. Escherichia coli strains 
Name                      Origin XL1‐Blue                     Stratagene BL21‐CodonPlus®(DE3)‐RIL            Stratagene C600                      Stratagene TOP10                      Invitrogen 
4.3. Plasmids 
Database entry   Name             Reference RJP88      YEplac181‐ASH1 (C3319)      Long et al., 1997 RJP122      p416‐GALS          Mumberg et al., 1994 RJP132      YEplac195‐ASH1 (C3431)      Long et al., 1997 RJP135      pFA6a‐HIS3MX6         Wach et al., 1997 RJP138      YCplac22            Gietz & Sugino, 1988 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RJP143      YEplac181           Gietz & Sugino, 1988 RJP145      YCplac111           Gietz & Sugino, 1988 RJP276      pYM2 (HA3, HIS3MX6)      Knop et al., 1999 RJP280      pYM6 (myc9, k.l.TRP1)      Knop et al., 1999 RJP292      pBS1479            Puig et al., 2001 RJP309      pRS426‐pGAL1‐ASH1        A. Jaedicke RJP393      pBS1761            Puig et al., 2001 RJP407      pSH47            Güldener et al., 1996 RJP413      YEplac195           Gietz & Sugino, 1988 RJP577      pRS426‐IST2 (pCJ15)        Jüschke et al., 2004 RJP673      pRS426‐WSC2 (pCJ55)      C. Jüschke RJP849      pKL187            Sanchez‐Diaz et al., 2004 RJP916      YCplac111‐SHE2        Du et al., 2008 RJP920      YCplac111‐GFP‐SHE2        Du et al., 2008 RJP957      pCM182            Garí et al., 1997 RJP1098      YCplac111‐SHE3N‐SHE2      Du et al., 2008 RJP1100      YCplac22‐SHE3N‐SHE2      Du et al., 2008 RJP1101      YCplac22‐SHE2          Du et al., 2008 RJP1150      pRS313‐SHE2(N36S, R63K)     Du et al., 2008 RJP1213      pFA6a‐natNT2          Janke et al., 2004 RJP1218      pYM17 (HA6, natNT2)       Janke et al., 2004 RJP1220      pYM19 (myc9, HIS3MX6)      Janke et al., 2004 RJP1243      pYM44 (yeGFP, HIS3MX6)      Janke et al., 2004 RJP1279      pYM‐N32 (HA3, pGALS, natNT2)    Janke et al., 2004 RJP1400      YEplac195‐LOC1‐HA6       this study RJP1474      pCM182‐LOC1‐HA6        this study RJP1382      p416‐GALS‐LOC1‐HA6      this study RJP1508      YCplac111‐LOC1‐HA6       this study RJP1511      YCplac111‐LOC1‐5´‐UTR      this study RJP1518      p416‐GALS‐KHD1‐HA6      this study RJP1521      YCplac111‐LOC1(aa65‐204)‐HA6   this study RJP1522      YCplac111‐LOC1(aa130‐204)‐HA6  this study RJP1523      YCplac111‐LOC1(aa158‐204)‐HA6  this study RJP1541      pFA6a‐HIS3MX6‐pGAL1‐HA3    Longtine et al., 1998 RJP1593      YCplac111‐GFP‐SHE2(aa1‐236)    this study RJP1594      YCplac111‐GFP‐SHE2(aa1‐226)    this study RJP1595      YCplac111‐GFP‐          this study SHE2(N36S, R63K; aa1‐236) RJP1595      YCplac111‐GFP‐          this study SHE2(N36S, R63K; aa1‐226) RJP1597      YCplac22‐SHE3N‐SHE2      Du et al., 2008 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RJP1598      YCplac22‐2×NLS‐SHE3N‐SHE2    Du et al., 2008 RJP1609      YCplac22‐SHE2(Xho I)      this study RJP1610      TOPO‐MOD5_II          this study RJP1611      TOPO‐STP1_region_I        this study RJP1612      YCplac22‐SHE2‐MOD5_II      this study RJP1613      YCplac22‐1×STP1_I‐SHE2      this study RJP1614      YCplac22‐3×STP1_I‐SHE2      this study RJP1622      pTZ18U‐tdΔP6‐2 wt        Prenninger et al., 2006 RJP1623      pTZ18U‐tdΔP6‐2 SH1        Prenninger et al., 2006 RJP1624      pSU20            Prenninger et al., 2006 RJP1625      pSU18‐stpA          Zhang et al., 1995 RJP1628      pSU18‐LOC1          this study RJP1629      pSU18            this study RJP1687      pET28a(+)           Novagen RJP1688      pET28a(+)‐LOC1        M. Müller RJP1689      pET28a(+)‐stpA          this study 
4.4. Oligonucleotides All oligonucleotides used in this study were purchased from Thermo Scientific or MWG  Biotech  (now  Eurofins  MWG  Operon).  Oligonucleotides  are  listed  in alphabetical order with database number, name, and sequence. 
4.4.1. Directly labeled oligonucleotides 
4.4.1.1. Fluorescently labeled oligonucleotides for FISH of ASH1 mRNA Sequences  of  Cy3‐labeled  oligonucleotides  used  in  this  study  were  described  in Long  et  al.,  1997.  Asterisks  mark  amino‐modified  thymidine  residues  were  the fluorochrome was bound. 5´‐GCTT*GCCTTGTTGAATT*CTGGTGAATT*GCCTGGTGTT*AATGAGGAAATT*GG 5´‐GATGCCTT*AGTGATGGT*AGGCTTTGTTGT*GGGCGCTCCGGT*CTCTTAGAT*A 5´‐GGAACTT*GGACGACCTAGT*CGATTCCAATT*CCTTGCCGT*AATTGAAACT*AT 5´‐AT*GGTTCTATT*GGTTGGTGGACT*CATCGGCGGTGT*GACGGGAGGAGTAAT*A 5´‐AAGCT*TTGAAACTGTT*CGTCTTTTTGT*GACTGGCATTT*GGCATGGGAAAT*G 




4.4.2.1. Oligonucleotides for ASH1 probe synthesis RJO176  ASH1 ORF297 fw  5´‐CCAATAGAACCATGGAGCGC RJO217  ASH1 3´‐UTR rev  5´‐GAAGATGCCGCGGCGTG 
4.4.2.2. Oligonucleotides for IST2 probe synthesis RJO671  IST2_pr1 fw    5´‐CTATACTTATTTGCACG RJO675  IST2_pr1 revT7    5´‐taatacgactcactataggGGCCAATATTGAAAAGGC RJO672  IST2_pr2 fw    5´‐GGAAAGCTGTGCTTTATAG RJO676  IST2_pr2 revT7    5´‐taactataggCCACGAGTGGTTTATTG RJO673  IST2_pr3 fw    5´‐CAGCCTGCCTCTTCTGCC RJO677  IST2_pr3 revT7    5´‐taatacgactcactataggCCGCAACACCATATGAG RJO674  IST2_pr4 fw    5´‐CGATGCTGCCACTAAG RJO678  IST2_pr4 revT7    5´‐taatacgactcactataggGTGATGATGATGGTGGGGC 
4.4.2.3. Oligonucleotides for WSC2 probe synthesis RJO2894  WSC2_pr1 fw    5´‐GCACCTAGATCTCATACACAAGTC RJO2895  WSC2_pr1 revT7  5´‐cgttaatacgactcactatagggCCTGCGTCAAAGACTGTAACTG RJO2896  WSC2_pr2 fw    5´‐CTACTGCTACCTCAACATCGAC RJO2897  WSC2_pr2 revT7  5´‐cgttaatacgactcactatagggAGTGCTAGAGGAAGTGGTGG RJO2898  WSC2_pr3 fw    5´‐CAGTCCGTGGTTTCTCAAGC RJO2899  WSC2_pr3 revT7  5´‐cgttaatacgactcactatagggCCAGTGAGTACGGCTGGTAC RJO2900  WSC2_pr4 fw    5´‐GCCACTTATGATCTGCCGAC RJO2901  WSC2_pr4 revT7  5´‐cgttaatacgactcactatagggGTCAGCGCAAAGAACTATTATT 
4.4.3. Oligonucleotides for gene disruption 
Δarx1 fw:  RJO2955  5´‐ACTTTTAAGAAAAAACCCGACCCGACTAATATTGCTAAAACTATCcgtacgctgcaggtcgac rev: RJO2956  5´‐ATACTTATATTATTTATATACTAGCTTTAGAAATGATGAAGTTTCatcgatgaattcgagctcg 
Δkhd1 fw:  RJO1292  5´‐CGGGTAACTTAGAGACAGCATTAGTATATATACCAGCCcagctgaagcttcgtacgc rev: RJO1293  5´‐GTTTTGTCTGTGTGGGACGTGCGCACGCACACGTATATAgcataggccactagtggatctg 
Δlhp1 fw:  RJO3179  5´‐TCTATTTGGTTCTACTGGAACTAAAGTAGCATCTGCAAAGAAGTAcgtacgctgcaggtcgac rev: RJO3180  5´‐ATATGCTATGATAATGAGATACGAGAACCAGAAGAAACACAAGAAatcgatgaattcgagctcg 
Δloc1 fw:  RJO691  5´‐GGTTAGATATCTGTAAATCTATACAATTAAGGAAAGATGGCACCcagctgaagcttcgtacgc rev: RJO692  5´‐ATACAACAGACTTATCCGTATTTAGTTTAGTCAATCAAACgcataggccactagtggatctg fw:  RJO2326  5´‐TTATAAGGTTAGATATCTGTAAATCTATACAATTAAGGAAAGATGcgtacgctgcaggtcgac rev: RJO2327  5´‐ATTATACAACAGACTTATCCGTATTTAGTTTAGTCAATCAAACTAatcgatgaattcgagctcg 
Δlsm7 fw:  RJO2522  5´‐AGCAGCACTTTGTTTACTACACAGAACATTAACCAAAAAAACcgtacgctgcaggtcgac rev: RJO2523  5´‐AACTGTAAGGAAGGGAGTTTATATGAGATTATATTATTAAACatcgatgaattcgagctcg 
Δltv1 fw:  RJO2959  5´‐GTATAGTATTTCAAAGACTTTAAGGGGAATATAAAAAGCACGAAGcgtacgctgcaggtcgac rev: RJO2960  5´‐CACAGTACTTGTAATGTAGGTGCTTTCTCATCTCATTCTACTCCTatcgatgaattcgagctcg 
Δmrt4 fw:  RJO2516  5´‐ATCACTGTCTATCGTCCATAAAAGATTTATTATAGTTGAATCcgtacgctgcaggtcgac rev: RJO2517  5´‐TACAATGGTCTATTAAAAAAGGCTTCCAAATAATAGTTCAGCatcgatgaattcgagctcg 
Δnop6 fw:  RJO2963  5´‐CTAATGTAGAGGACAGGATAGAGATTGAAGACGTCTACAGCTAAAcgtacgctgcaggtcgac rev: RJO2964  5´‐TTTCTTTTTGTCTAAGATACATGGCGTATAAAATTAAATTTGTACatcgatgaattcgagctcg 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Δnop16 fw:  RJO2757  5´‐TTAATATCAAACTGCAAATACACTAAGTAAAAAAAGTTGCATACAcgtacgctgcaggtcgac rev: RJO2758  5´‐CATATATAAATATTACGTGGTAATCAATTGGTAGTTGCCATTGGTatcgatgaattcgagctcg 
Δpuf6 fw:  RJO2328  5´‐TACTGAAATAAAGCACAATCAGGAATAACAAATTAACTGACAATGcgtacgctgcaggtcgac rev: RJO2329  5´‐AGATGCTTATATACCAAATATTGTGACTTTATCGTAGAAAATTTAatcgatgaattcgagctcg 
Δrrp8 fw:  RJO2971  5´‐TATATATATTATATCAAACAAATAAGGACGTTAACGAAATTTTATcgtacgctgcaggtcgac rev: RJO2972  5´‐AAAAGAAAAAACAATATTAAAATATGAAAATGACGGATGAAGTCGatcgatgaattcgagctcg 
Δshe2 fw:  RJO2420  5´‐GTAAACCCTCCTTAATTTTCCTTTTGCATAATACCAGACACTTAAAAcgtacgctgcaggtcgac rev: RJO2071  5´‐ATTAACTAGTGGTACTTATTTGCTCTTTTTGAGCTAAAAACTGAAGGCCatcgatgaattcgagctcg 
Δssf1 fw:  RJO2975  5´‐AATAAAAGAGTATAATCCAGATATAGCAGACAATAAAATTTCAAGcgtacgctgcaggtcgac rev: RJO2976  5´‐GGATAGCCAGGCTTAACTAAAATTTTCTTGGTACCGGAGAACAATatcgatgaattcgagctcg 







aa1­70 fw:  RJO2782  5´‐TTGGCTAGACTTTATGGTGCGAAGAAGGACAAGAAGGGGAAATATcgtacgctgcaggtcgac Loc1‐Knop fw:  RJO2339  5´‐TAGTGAAAGTAAAACTGAAGGAAGGAAGGTAAAAAAAGTCTCATTTGCTCAAcgtacgctgcaggtcgac rev: RJO2340  5´‐GTTATATATTATACAACAGACTTATCCGTATTTAGTTTAGTCAATCAAACTAatcgatgaattcgagctcg Longtine‐Loc1 fw:  RJO3000  5´‐TGAAAAAGAAGATCGAATGCAAACCATAAATTAGAGATCTAATTGgaattcgagctcgtttaaac rev: RJO3001  5´‐TTCTCTTCTCAGATTTTGTCTCTTAGAAGGTTTCTTTGGTGCCATgcactgagcagcgtaatctg Loc1‐TAP fw:  RJO2316  5´‐AGTAAAACTGAAGGAAGGAAGGTAAAAAAAGTCTCATTTGCTCAAtccatggaaaagagaag rev: RJO2317  5´‐TATATTATACAACAGACTTATCCGTATTTAGTTTAGTCAATCAAAtacgactcactataggg Loc1‐td fw:  RJO2716  5´‐TAAACTGAAAAAGAAGATCGAATGCAAACCATAAATTAGAGATCTAATTGattaaggcgcgccagatctg rev: RJO2717  5´‐GCGACTTCTCTTCTCAGATTTTGTCTCTTAGAAGGTTTCTTTGGTGCCATggcacccgctccagcgcctg TAP‐Loc1 fw:  RJO2400  5´‐AAATTATAAGGTTAGATATCTGTAAATCTATACAATTAAGGAAAGgaacaaaagctggagctcat rev: RJO2401  5´‐TTCTCTTCTCAGATTTTGTCTCTTAGAAGGTTTCTTTGGTGCCATcttatcgtcatcatcaagtg Puf6‐Knop fw:  RJO2037  5´‐GATGAAAGTAACAAAGGCTCTCAGCTTTTGGCTAAATTGTTAAAAcgtacgctgcaggtcgac rev: RJO2038  5´‐GTACAGATGCTTATATACCAAATATTGTGACTTTATCGTAGAAAATatcgatgaattcgagctcg 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Puf6‐TAP fw:  RJO2319  5´‐GATGAAAGTAACAAAGGCTCTCAGCTTTTGGCTAAATTGTTAAAAtccatggaaaagagaag rev: RJO2320  5´‐TACAGATGCTTATATACCAAATATTGTGACTTTATCGTAGAAAATtacgactcactataggg She2‐Knop fw:  RJO2070  5´‐TGATGTTGTCGCTACTAAATGGCATGACAAATTTGGTAAATTGAAAAACcgtacgctgcaggtcgac rev: RJO2071  5´‐ATTAACTAGTGGTACTTATTTGCTCTTTTTGAGCTAAAAACTGAAGGCCatcgatgaattcgagctcg 
4.4.5. Oligonucleotides for sequencing or verifying knockouts/taggings RJO2957  ARX1 5´‐UTR fw    5´‐GATGAGATGAGCTAAAGCATC RJO2958  ARX1 3´‐UTR rev  5´‐CTGAGCAAATGAACCAAGCGG RJO1763  degron check fw   5´‐CTGGTGCAGGCGCTGGAGCG RJO1764  degron check rev  5´‐CGCTCCAGCGCCTGCACCAG RJO2337  GAL1 prom fw    5´‐TAATACTTTCAACATTTTCGG RJO2210  HIS3MX6   fw    5´‐GCTCCCTTACCTGAAGAGTCG RJO2633  HIS3MX6 outfw    5´‐GTAATGACCATCATCGTGCTG RJO2632  HIS3MX6 rev    5´‐CGACTCTTCAGGTAAGGGAGC RJO2027  kanMX fw      5´‐TGATTTTGATGACGAGCGTAAT RJO2495  kanMX outfw    5´‐GCAGTTTCATTTGATGCTCGATGAG RJO2026  kanMX rev     5´‐CTGCAGCGAGGAGCCGTAAT RJO1751  KHD1 5´‐UTR fw   5´‐CAGTTTGCCAATATAAGCGC RJO1752  KHD1 3´‐UTR rev  5´‐AATCTAGAGGAAACGCCAATAGTCTCGA RJO2020  K.l. TRP1 fw    5´‐GAGGTTCCAGTTCCCACAGG RJO2636  K.l.TRP1 outfw    5´‐CGGGAACACAAATGATAC RJO2021  K.l. TRP1 rev    5´‐CCTGTGGGAACTGGAACCTC RJO2637  Knop‐tag rev    5´‐CGAGGAGCCGTAATTTTTGC RJO3181  LHP1 5´‐UTR fw    5´‐CCCTTCACCTTAAACCCTTCC RJO3182  LHP1 3´‐UTR rev  5´‐CAAGAGACTCTCTCTCTGACTGC RJO2243  LOC1 5´‐UTR fw    5´‐GAAGTAACGGCGATGAGGTG RJO2718  LOC1 ORF120 rev  5´‐CAAGCTTACTCTCAGCTATATC RJO2318  LOC1 ORF122 fw  5´‐AGCTGAGAGTAAGCTTGAAAA RJO2244  LOC1 3´‐UTR rev  5´‐GAACAGAGTAGCATCAGCC RJO2331  LOC1 3´‐UTR rev 2  5´‐GAAATCTTCTAGGAAGACGTG RJO2524  LSM7 5´‐UTR fw   5´‐GAAAACAGACAACTGGGAAAC RJO2525  LSM7 3´‐UTR rev  5´‐AACTATGTAGCGCATACTATG RJO2961  LTV1 5´‐UTR fw    5´‐GTCAAATAAAAATTTTAAGCG RJO2962  LTV1 3´‐UTR rev  5´‐GCCGCGTTTCATAATTATTAC MWG   M13 uni (‐21)    5´‐TGTAAAACGACGGCCAGT MWG   M13 rev (‐29)    5´‐CAGGAAACAGCTATGACC RJO2514  MRT4 5´‐UTR fw   5´‐ACCATTAGGACTTTACCCGGC RJO2515  MRT4 3´‐UTR rev  5´‐GCTAAAGAGCTGTGAAGATCA RJO2330  natNT2 fw      5´‐AATCGGACGACGAATCGGACG RJO2496  natNT2 outfw    5´‐CGCTCTACATGAGCATGCCCTGCCC 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RJO2965  NOP6 5´‐UTR fw   5´‐CATTCCTGAAAATTTTCTAAG RJO2966  NOP6 3´‐UTR rev  5´‐GGAAGAGTTTACGTATTGGGC RJO2759  NOP16 5´‐UTR fw  5´‐AACGTTACCCGAACAGAACAC RJO2759  NOP16 3´‐UTR rev  5´‐CTACCTATAGAGCCTTTGTGG RJO2780  PUF6 5´‐UTR fw    5´‐GTATTTCGAAGGTGAAAGCG RJO2321  PUF6 ORF491 fw  5´‐ATTCCAGTATATTGACAGAGA RJO2332  PUF6 3´‐UTR rev  5´‐GTGAGGTGAGGATTCGCTATC RJO2781  PUF6 3´‐UTR rev 2  5´‐CCTGCACTTTCAATGAGATC RJO2973  RRP8 5´‐UTR fw    5´‐CTCGCATCGTCAATAACGGCG RJO2974  RRP8 3´‐UTR rev  5´‐GTGGAGTACTTCTTCTAGATG RJO1813  SHE2 5´‐UTR fw    5´‐CTTATAGAATGGTTCTTCGTGCATGCC RJO1816  SHE2 ORF100 rev  5´‐CGCAAATGACTGATGAACTTGTTCAGC RJO2069  SHE2 ORF262 fw  5´‐GAGGCGGATTCGTTTGACAAG RJO2068  SHE2 ORF486 rev  5´‐CAAAGACTCAATCATCCATTGAG RJO1964  SHE2 3´‐UTR rev  5´‐CCTAAATTGGGGTCCCTCCCACATCAGAGG RJO2977  SSF1 5´‐UTR fw    5´‐CGAAATTGAAATTTTTCACTG RJO2978  SSF1 3´‐UTR rev   5´‐GCTATGATTTAAAAGACAAAG MWG  T3        5´‐AATTAACCCTCACTAAAGGG MWG  T7        5´‐TAATACGACTCACTATAGGG MWG  T7 term      5´‐CTAGTTATTGCTCAGCGGT RJO2422  T7 term rev    5´‐GCTAGTTATTGCTCAGCGG RJO166  YXplac fw      5´‐CCCGACTGGAAAGCGGGCAG RJO167  YXplac rev     5´‐GGAGAAAATACCGCATCAGGC 
4.4.6. Oligonucleotides for cloning RJO2933  KHD1 fw (Spe I)      5´‐TTTTTTactagtATGTCACAGTTCTTCGAAGCT RJO2856  Knop rev pYM3 (Hind III)  5´‐TTTTTTaagcttTATAGTGAATGATCGTTCCAC RJO2818  Knop‐tag rev (Apa I)    5´‐TTTTTTgggcccCGAGGAGCCGTAATTTTTGC RJO2635  Knop‐tag rev (Kpn I)    5´‐TTTTTTggtaccCGAGGAGCCGTAATTTTTGC RJO2580  LOC1 5´‐UTR fw (Sph I)  5´‐TTTTTTgcatgcGTTTGGGAAGGAAAGCAG RJO2929  LOC1 5´‐UTR rev (Bam H I)  5´‐TTTTTTggatccCTTTCCTTAATTGTATAGATT RJO2382  LOC1 fw (Bam H I)    5´‐TTTTTTggatccATGGCACCAAAGAAACCTTCT RJO2817  LOC1 fw (Cla I)      5´‐TTTTTTatcgatATGGCACCAAAGAAACCTTCT RJO2536  LOC1 fw (Spe I)      5´‐TTTTTTactagtATGGCACCAAAGAAACCTTCT RJO562  LOC1 fw (Xho I)      5´‐TTTctcgagGTTTGGGAAGGAAAGC RJO2930  LOC1 ORF65 fw (Bam H I)  5´‐TTTTTTggatccatgAAGGACAAGAAGGGGAAATATTC RJO2952  LOC1 ORF65 fw (Kpn I)  5´‐TTTTTTggtaccatgAAGGACAAGAAGGGGAAATATTC RJO2931  LOC1 ORF130 fw (Bam H I)  5´‐TTTTTTggatccatgGCTAGAAGATTAGAAGAGATAC RJO2953  LOC1 ORF130 fw (Kpn I)  5´‐TTTTTTggtaccatgGCTAGAAGATTAGAAGAGATAC RJO2932  LOC1 ORF158 fw (Bam H I)  5‐TTTTTTggatccatgAAAAAAGACGAGATTAAAAA´GAAG RJO2954  LOC1 ORF158 fw (Kpn I)  5‐TTTTTTggtaccatgAAAAAAGACGAGATTAAAAAGAAG 
Materials 
89 
RJO3187  LOC1 rev (Eco R I)    5´‐TTTTTTgaattcCTATTGAGCAAATGAGACTTTTTTTAC RJO2383  LOC1 rev (Xho I)     5´‐TTTTTTctcgagTTGAGCAAATGAGACTTTTTTTAC RJO2421  LOC1‐tag rev (Pst I/Eco R I) 5´‐TTTTTTgaattcctgcagCGAGGAGCCGTAATTTTTGC RJO3162  MOD5_II fw (Xba I)    5´‐TTTTTTtctagaCCCCCCGGGCCCCCCATGTCTAAAAAAGT TATAGTG RJO3156  MOD5_II fw (Xho I)    5´‐TTTTTTctcgagATGTCTAAAAAAGTTATAGTG RJO3163  MOD5_II rev (Xba I)    5´‐TTTTTTtctagaCAAGTTGGATTTATGTCTTCTG RJO3157  MOD5_II rev (Xho I)    5´‐TTTTTTctcgagGGGGGGCCCGGGGGGAAGTTGGATTTA TGTCTTCTG RJO2518  2×NLS fw (Bam H I)    5´‐TTggatccCCCCCCGGGCCCCCCGGTA RJO3127  2×NLS fw (Bam H I) 2    5´‐TTTTTggatccCCAAAAAAGAAGAGAAAGGTACC RJO3160  2×NLS fw (Xba I)    5´‐TTTTTTtctagaCCCCCCGGGCCCCCCggtacc RJO3137  2×NLS fw (Xho I)    5´‐TTTTTTctcgagCCCCCCGGGCCCCCCggtacc RJO3128  2×NLS rev (Bam H I)    5´‐TTTTTggatccGGGCCCGGGTACCTTTCTCTTCTTTTTTG RJO2498  2×NLS rev (Bgl II)    5´‐CGCagatctGGGCCCGGGTACCTT RJO3161  2×NLS rev (Xba I)    5´‐TTTTTTtctagaGGGCCCGGGTACCTTTCTCTT RJO3138  2×NLS rev (Xho I)    5´‐TTTTTTctcgagGGGCCCGGGTACCTTTCTCTT RJO3107  PUF6 fw (Sac I)      5´‐TTTTTTgagctcATGGCACCTTTAACCAAGAAG RJO2855  PUF6 fw (Spe I)      5´‐TTTTTTactagtATGGCACCTTTAACCAAGAAG RJO3108  PUF6 rev (Xho I)     5´‐TTTTTTctcgagTTTTAACAATTTAGCCAAAAG RJO2854  SHE2 fw (Spe I)      5´‐TTTTTTactagtATGAGCAAAGACAAAGATATC RJO3101  SHE2 ORF236 rev (Stu I)  5´‐TTTTTTaggcctcaTTTGTCATGCCATTTAGTAGC RJO3102  SHE2 ORF226 rev (Stu I)  5´‐TTTTTTaggcctcaCAAGGCGCTCAGCTTACCATC RJO3103  SHE2 ORF216 rev (Stu I)  5´‐TTTTTTaggcctcaGTGCCACGCAGCTGACAAGGT RJO3104  SHE2 ORF206 rev (Stu I)  5´‐TTTTTTaggcctcaTTCTTCGGAGTTGACAGGAAG RJO3164  STP1 region I fw (Xba I)  5´‐TTTTTTtctagaCCCCCCGGGCCCCCCATGCCCTCTACCA CGCTACTG RJO3154  STP1 region I fw (Xho I)  5´‐TTTTTTctcgagATGCCCTCTACCACGCTACTG RJO3165  STP1 region I rev (Xba I)  5´‐TTTTTTtctagaATAATGATGACTTAGATCTGG RJO3155  STP1 region I rev (Xho I)  5´‐TTTTTTctcgagGGGGGGCCCGGGGGGATAATGATGACTT AGATCTGG RJO3388  stpA fw (Bam H I)    5´‐TTTTTTggtaccATGTCCGTAATGTTACAAAGT RJO3389  stpA +Stop rev (Xho I)   5´‐TTTTTTctcgagTTAGATCAGGAAATCGTCGAG RJO3390  stpA –Stop rev (Xho I)   5´‐TTTTTTctcgagGATCAGGAAATCGTCGAGAGA 





10× PBS(T)                 1 M PKi pH 7.5 
(phosphate­buffered saline)(Tween)       (inorganic potassium phosphate) 1.37 M (80 g) NaCl              86.6 ml 1 M K2HPO4 27 mM (2.0 g) KCl              13.4 ml 1 M KH2PO4 20 mM (2.4 g) KH2PO4             adjust pH 10 mM (17.8 g) Na2HPO4·2 H2O          store @ RT PBST: 0.1% (v/v) (1 ml 100%) Tween‐20 ad 1 l water store @ RT 
 
1 M PNai pH 7.0 (inorganic sodium phosphate)    20×  SSC (saline­sodium citrate) 
57.7 ml 1 M Na2HPO4      3 M (175,3 g) NaCl 
42.3 ml 1 M NaH2PO4      0.3 M (88,2 g) sodium citrate 
adjust pH                  ad 1000 ml water 
store @ RT                 store @ RT 
 
10× TBS (Tris­buffer saline) 1.37 M (80 g) NaCl 27 mM (2.0 g) KCl 125 mM (125 ml 1 M) Tris pH 7.4 ad 1 l water store @ RT 
4.5.2. Media (plates supplemented with 20 g/l Bacto™ Agar) Yeast media were  prepared  as  described  (Adams,  1998),  sometimes with minor changes  in  composition.  E.  coli  media  were  prepared  as  described  previously (Sambrook & Russell, 2001).   
LB (Luria­Bertani Broth)           Presporulation (plates only!) 10 g Bacto™ Tryptone            5 g glucose 5 g Bacto™ Yeast Extract          3 g nutrient broth 10 g NaCl                1 g yeast extract ad 1 l water               ad 100 ml water autoclave                 autoclave  before use add respective antibiotic, if needed   store @ 4°C and use within 2 weeks  
SDC dropout (Synthetic Dextrose Complete)   SGC dropout (Synthetic Galactose Complete) 6.7 g YNB                6.7 g YNB dropout mix as required           dropout mix as required ad 900 ml water             ad 900 ml water autoclave                 autoclave before use add 100 ml 20%(w/v) glucose     before use add 100 ml 20%(w/v) galactose  
SOB (Super Optimal Broth)         SOC (Super Optimal Broth with Catabolite  20 g Bacto™ Trypton             Repression) 5 g Bacto™ Yeast Extract           See SOB 8.55 mM (0.5 g) NaCl             before use add 20 mM (10 ml 2.2 M) Glc  2.5 mM (2.5 ml 1 M) KCl           store 15 ml aliquots @ ‐20°C ad 1.0 l water (adjust pH to 7 (with NaOH)) autoclave before use add 10 mM (5 ml 2 M) MgCl2 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Sporulation (plates)            Sporulation (solution) 10 g potassium acetate           1 g potassium acetate 1 g yeast extract             0.05 g zinc actetate 2 g synthetic complete mix           ad 100 ml water 2.5 ml 20% (w/v) glucose           autoclave ad 500 ml water autoclave 
 
SRC dropout (Synthetic Raffinose Complete)   TBYE (Tryptone Broth Yeast Extract) 6.7 g YNB                10 g Bacto™ Tryptone dropout mix as required           5 g Bacto™ Yeast Extract ad 900 ml water             5 g NaCl autoclave                 ad 1 l water before use add 100 ml           20%(w/v)  raffinose   autoclave before use add respective antibiotic, if needed 
YP (Yeast Extract Peptone)  11 g Bacto™ Yeast Extract 22 g Bacto™ Peptone 55 mg adenine hemisulfate ad 900 ml water autoclave before use add 100 ml 20% (w/v) of respective sugar (YPD – Glc, YPG – Gal, YPR – Raf)  
4.5.3. Consumables 
Name                    Supplier Calmodulin Affinity Resin              Stratagene Econo Column®                  Bio‐Rad Filter paper 3MM                Whatman Gene Pulser® Cuvettes 0.2 cm electrode gap        Bio‐Rad glass beads (∅ 0.2 – 0.3 mm)            Roth IgG Sepharose™ 6 Fast Flow            Amersham mini Quick Spin Columns              Roche Applied Science Mobicols                    MoBiTec NuPAGE® Novex 4‐12% Bis‐Tris Gel (1.0 mm)      Invitrogen PositiveTM Membrane              Qbiogene Sterile Filter units (0.45 μm, 0.22 μm)          Millipore SW40 polycarbonate tubes              Beranek 
4.5.4. Devices 
Name                    Supplier Biofuge fresco                  Heraeus Electroporation device Micropulser™          Bio‐Rad Fluorescence Image Reader LAS‐3000          Fujifilm Fluorescence Microscope BX60            Olympus Gradient Station                 BioComp Instruments Mini Hybridization Oven              MWG Biotech 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SE Mighty Small II gel electrophesis system        Hoefer Sequi‐Gen® GT Nucleic Acid Electrophoresis Cell (21×40 cm)  Bio‐Rad Thermocycler                   MJ Research Thermomixer compact              Eppendorf Typhoon™ Variable Mode Imager           Amersham UV Stratalinker                  Stratagene Vibrax VXR basic                IKA 
4.5.5. Commercial Kits 
Name                    Supplier Colloidal Blue Staining Kit              Invitrogen FastPlasmid™ Mini Kit               Eppendorf Prime‐It® II Random Primer Labeling Kit        Stratagene QuikChange® Site‐Directed Mutagenesis Kit        Stratagene QIAquick® Gel Extraction Kit            Qiagen QIAquick® PCR Purification Kit            Qiagen QIAprep® Spin Miniprep Kit             Qiagen SilverQuest™ Silver Staining Kit            Invitrogen TOPO TA Cloning Kit                Invitrogen 
4.5.6. Stockists 
Company                    Contact A. Hartenstein Laborbedarf GmbH          www.laborversand.de abcam                    www.abcam.com Ambion, Inc.                  www.ambion.com Amersham (now GE Healthcare)            www.gehealthcare.com Axon Labortechnik                www.axon‐lab.de Beranek Laborgeräte                www.laborgeraete‐beranek.de BioComp Instruments, Inc. (via Science Services GmbH)    www.scienceservices.de Bio‐Rad                    www.bio‐rad.com Carl Roth                    www.carl‐roth.de Covance                    www.covance.com Eppendorf AG                  www.eppendorf.de Fermentas Life Sciences              www.fermentas.com Fluka (via Sigma‐Aldrich)              www.sigmaaldrich.com Gentaur Molecular Products            www.gentaur.com Heraeus (via VWR)                www.vwr.com Hoefer®, Inc.                  www.hoeferinc.com IKA® Labortechnik                www.ika.de Invitrogen Corporation              www.invitrogen.com Jackson ImmunoResearch Europe, Ltd.          www.jireurope.com 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5.1.1.1. Standard agarose gel electrophoresis Agarose gel electrophoresis is used to separate DNA fragments of different lengths. The  method  is  described  in  detail  in  Sambrook  &  Russell,  2001.  In  this  work electrophoresis was performed routinely with 1.0% (w/v) agarose gels containing 0.2 μg/ml ethidium bromide, with 1×TAE as electrophoresis buffer. To assay  the length of the fragments, 250 ng of a DNA ladder (see section 4.1.4) was used. 
6× loading dye  (LD)          50×  TAE  40% (w/v) Sucrose          2 M (121 g) Tris 0.25% (w/v) Bromophenol blue      100 mM EDTA pH 8,0 0.25% (w/v) Xylene cyanol FF      1 M acetic acid store aliquots @ ‐20°C         autoclave store @ RT  
5.1.1.2. Preparative agarose gel electrophoresis For purification of DNA  fragments after digestion with  restriction endonucleases (section 5.1.2), 1.0% gels were cast with broad lanes, enabling loading of up to 100 μl of the digestion sample per lane. 
5.1.2. Digestion of DNA with restriction endonucleases In this work, a variety of prokaryotic restriction endonucleases were used to digest DNA in order to prepare defined fragments for cloning or to check cloned plasmids for  presence  and  correct  orientation  of  inserted  DNA  fragments.  The  reactions were  generally  set  up  in  1.5  ml  tubes  as  test  digests  to  control  cloning  (20  μl reaction mix) or as preparative digests (100 μl reaction mix). 
 




20  μl  reactions  were  incubated  for  2  h  at  the  respective  temperature,  100  μl reactions  were  for  5  h  to  overnight.  Preparative  digests  were  additionally incubated with Calf Intestine Alkaline Phosphatase (CIAP) for 30 min at 37°C. The different restriction enzyme activity is due to different concentrations provided by the manufacturer.  10  μl  of  the  20  μl  reactions  were  analyzed  on  a  1.0%  agarose  gel  (see  section 5.1.1.1); the 100 μl reactions were loaded entirely onto broad lanes, and the bands of interest were cut out after the gel course.  
5.1.3. Purification of DNA fragments from agarose gels DNA fragments of  interest were cut out  from agarose gels and purified using  the commercial  QIAquick®  gel  extraction  kit,  following  the  manual  provided  by  the manufacturer. 
5.1.4. Ligation of DNA fragments Ligation  of  digested  DNA  fragments was  carried  out  with  T4  DNA  Ligase  either according to the protocol from the Quick Ligation™ Kit or according to the protocol provided with the enzyme. For a standard ligation reaction, 1 µl vector was mixed with 9 µl  insert  (depending on  concentration),  2 µl  10×  ligation buffer,  and 7 µl sterile water. After addition of 1 µl of ligase the mixture was incubated for at least 30 min at room temperature. 
5.1.5.  Polymerase chain reaction (PCR) Using  the  polymerase  chain  reaction  (PCR)  fragments  of  DNA  can  rapidly  be amplified and subsequently used for cloning. The principles are described in detail in Sambrook & Russell, 2001. The program for all PCR reactions in this work was described previously  (Janke et al., 2004,  see Table 4). 10 μl of each sample were analyzed on a 1.0% agarose gel after the end of amplification. All PCR products for further  use were  subsequently  purified  using  the  QIAGEN®  PCR  purification  kit, eluted in 30 μl of sterile water and stored at –20 °C.  
Table 4   PCR program (SJKNOP) Denaturation  Annealing  Elongation  Number of cycles 3 min 95°C  30 s 54°C  2 min 40 s 68°C  1 1 min 95°C  30 s 54°C  2 min 40 s 68°C  10 1 min 95°C  30 s 54°C  2 min 40 s 68°C +20 s/cycle  20 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5.1.5.1. Yeast colony PCR A small amount of yeast cells was suspended in 100 µl 0.02 M NaOH in a safe‐lock 1.5 ml tube, 250 µl glass beads (∅ 0.2 – 0.3 mm) were added, and the mixture was incubated  for  5 min  at  99°C  and  1400  rpm  (thermomixer).  Glass  beads  and  cell debris were spun down and 5 µl of the supernatant were used as template for PCR.  For each 50 μl reaction the respective volumes of the following components were mixed in a 0.2 ml tube:  28.14 µl sterile water 5 µl 25 mM MgCl2 5 µl 10× PCR buffer 1 µl DMSO 3 µl dNTPmix (2.5 mM each)  1.28 µl 25 µM forward (fw) primer 1.28 µl 25 µM reverse (rev) primer 5 µl template DNA 0.3 µl Taq polymerase   
5.1.5.2. Proof‐reading PCR for cloning Proof‐reading  PCR was  carried  out  using  Herculase®  II  or  a  2:1 mixture  of  Taq polymerase and Vent Polymerase. Pipetting schemes are shown in Table 5. 
Table 5   Proof-reading PCR   Herculase®  Taq/Vent mixture sterile water  32 µl  33.4 µl polymerase buffer  10 µl 5×  5 µl 10× 25 mM MgCl2  0  2.5 µl dNTP mix (2.5 mM each)  5 µl  5 µl 25 µM fw primer  0.5 µl  1 µl 25 µM rev primer  0.5 µl  1 µl template DNA  1 µl  1 µl polymerase  1 µl  0.6 µl   
5.1.6. Extraction and ethanol precipitation of nucleic acids In this study, DNA and RNA for various purposes have been purified via classical phenol‐chloroform extraction (Sambrook & Russell, 2001). Simple extraction was done  by  addition  of  one  volume  of  phenol/chloroform/isoamylalcohol  (PCI) (25:24:1)  (pH  acidic  for  RNA  extraction)  to  the  sample,  vortexing  10  s,  and centrifuging 5 min at full speed and 4°C in a microfuge. For nucleic acids of higher purity, three rounds of extraction were performed, the first with phenol only, the second with the PCI mix, and the third with chloroform only. 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Subsequently,  nucleic  acids  were  precipitated  by  adding  0.1  volumes  of  3  M sodium acetate pH 5.2 and 2.2 volumes of ethanol to the sample, which was then incubated at –20°C for 30 min to complete precipitation before being centrifuged for 10 min at maximum speed in a microfuge at room temperature. After removal of the supernatant, the pellet was washed once in 70% (v/v) ethanol and dried for about 15 min at room temperature. It was then dissolved in water or a buffer used for subsequent reactions. 




5.1.9.1. Capillary transfer Transfer  of  RNAs  onto  positively  charged  membranes  (Northern  Blot)  was performed essentially as described (Sambrook & Russell, 2001). Purified RNA was loaded onto a 1.2% denaturing agarose gel, which was run at 80 V for about 4 h. The gel and a piece of positively charged membrane were equilibrated 10 min in water and 10 min in 10× SSC, then the capillary transfer sandwich was assembled in  a  buffer  reservoir  containing  10×  SSC  (from  bottom  to  top):  gel  tray  (upside down),  one  layer  Whatman  3MM  paper  (bridge  to  buffer  reservoir),  one  layer Whatman 3MM paper  in  the  size  of  the  gel,  the membrane,  the  gel with pockets oriented downwards,  three  layers Whatman 3MM paper,  a 10  cm stack of paper towels, and a glass plate with a filled 1 l bottle on top. After blotting overnight at 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room temperature, the sandwich was disassembled, the membrane was shaken 1 min  in  2×  SSC,  dried  at  room  temperature,  and  crosslinked with  UV  light  (30  s 1200 µJ/cm2).  To  control  for  efficient  transfer,  the membrane was  stained with methylene blue, destained with water, dried and stored at room temperature. 
10×  MOPS buffer            Methylene blue solution 0.2 M MOPS pH 7.0            0.4 M sodium acetate 20 mM sodium acetate          0.4 M acetic acid 10 mM EDTA pH 8.0            0.2% (w/v) Methylene blue  
1.2% denaturing agarose gel (150 ml)    RNA loading dye 1.8 g agarose              50% (v/v) glycerol 131.5 ml DEPC‐treated water        1 mM EDTA pH 8.0 (boil, cool to ≈60°C)            few grains Bromophenol blue 3.5 ml 37% formaldehyde          few grains Xylene cyanol FF 15 ml 10× MOPS   
5.1.9.2. Synthesis of radiolabeled probes 25 ng  PCR product  comprising  a  fragment  of  the  gene  of  interest were  used  for labeling with α‐[32P]‐dCTP. The procedure was carried out with a commercial kit following the manufacturer’s protocol. 
5.1.9.3. Hybridization Before actual hybridization,  the dried membrane was pre‐hybridized with 8.7 ml pre‐hybridization solution per 100 cm2 membrane for at least one hour at 65°C in a hybridization oven. Subsequently, radiolabeled probe was added and hybridized to  the membrane overnight  at 65°C  in  a hybridization oven. The membrane was washed twice briefly in 2× SSC, 0.1% SDS, twice for 20 min in 0.5× SSC, 0.1% SDS at 43°C  and  once  briefly  in  3  mM  Tris/HCl  pH  8.0,  before  being  exposed  to  a PhosphoImager screen overnight and analyzed with a Typhoon™ imager. 
20×  Scp              Scp/Sarc/DS 2 M NaCl              20 g dextran sulfate 0.6 M Na2HPO4            60 ml 20× Scp 0.02 M EDTA            ad 101 ml DEPC‐treated water adjust pH to 6.2 (HCl)          (heat gently) autoclave              7 ml 30% (v/v) sodium‐lauroyl‐sarcosine store @ RT             store @ RT 
 
Pre­hybridization solution 0.46 volumes DEPC‐treated water 0.54 volumes Scp/Sarc/DS 0.0046 volumes 10 mg/ml herring sperm DNA  
5.1.10. Mapping of 2´‐O‐methylated nucleotides and Ψ  residues Primer  extension  was  performed  to  map  2´‐O‐methylated  nucleotides  and pseudouridine  (Ψ)  residues  essentially  as  described  before  (Ganot  et  al.,  1999; 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Massenet  et  al.,  1999),  with  some  modifications.  First,  total  RNA  was  extracted from a logarithmically growing yeast culture as described in section 5.1.7.   
5.1.10.1. Reaction of RNA with CMC 10  µg  of  dried  total  RNA  were  used  for  reaction  with  N‐cyclohexyl‐N´‐β‐(4‐methylmorpholinium)‐ethylcarbodiimide p‐tosylate  (CMC)  as described  (Bakin & Ofengand,  1993).  In  brief,  30  µl  CMC  buffer  were  added  to  the  RNA,  and  the mixture  was  incubated  for  20  minutes  at  37°C  (water  bath).  The  reaction  was stopped by  addition of  100 µl  buffer A  and 700 µl  100% ethanol.  Samples were incubated  5  minutes  in  a  pre‐cooled  metal  block  at  ‐80°C  to  precipitate  RNA, before being centrifuged 5 min at full speed and 4°C in a microfuge. The pellet was washed once with 70% ethanol,  and  the precipitation with buffer A  and  ethanol was  repeated once. Then,  the pellet was air‐dried and dissolved  in 40 µl  50 mM SCB buffer, and incubated for 3 hours at 37°C. After precipitation of the RNA with buffer A and ethanol, the pellet was washed twice with 70% ethanol, air‐dried and dissolved in 20 µl DEPC‐treated water. 
CMC buffer          SCB buffer pH 10.4 170 mM CMC          8 ml 0.1 M Na2CO3 50 mM Bicine pH 8.3        2 ml 0.1 M NaHCO3 4 mM EDTA pH 8.0        10 ml DEPC‐treated water 7 M Urea  
Buffer A 300 mM sodium acetate pH 5.3 0.1 mM EDTA pH 8.0  
5.1.10.2. Primer extension Primer extension was performed in 20 µl samples with a Thermocycler. 5 µg RNA preparation  (either  total  or  CMC‐treated  RNA)  were  diluted  with  DEPC‐treated water to a final volume of 9 µl. 2 µl of 10 µM 5´‐FAM labeled primer (see section 4.4.1.2)  were  added,  and  samples  were  incubated  5  minutes  at  70°C  and subsequently  cooled  to  4°C.  After  addition  of  4  µl  5×  reaction  buffer,  2  µl nucleotide  mix,  1  µl  RNasin,  and  5  minutes  at  37°C,  2  µl  M‐MuLV  reverse transcriptase  were  added,  and  the  complete  extension  reaction  mixes  were incubated  for  one  hour  at  42°C,  before  being  heat‐inactivated  (10 min  at  70°C). Different  nucleotide  mixtures  were  used  for  mapping  of  Ψ  residues,  ribose‐methylated nucleotides,  and  sequencing  ladders.  For Ψ  detection,  a  standard 2.5 mM  each  dNTP  mix  was  used.  For  detection  of  2´‐O‐methylations,  dNTPs  were used at a  concentration of 0.004 mM each  (positive  control  reaction: 1 mM each 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dNTP; Maden  et  al.,  1995).  For  sequencing  ladders,  dNTP/ddXTP mixtures were used, with three dNTPs at 2.5 mM each,  the fourth at 1.6 mM plus 0.9 mM of the corresponding ddNTP. With  the  reactions  completed,  180  µl  DEPC‐treated  water,  20  µl  3  M  sodium acetate  pH  5.2,  and  440  µl  ethanol  were  added  to  the  samples,  DNAs  were precipitated  for at  least  two hours at  ‐20°C,  centrifuged, washed with 70% (v/v) ethanol, and the resulting pellet was taken up in 10 µl loading buffer without dyes (bromophenol blue and xylene cyanol quench fluorescence). 




5.2.1. SDS‐PAGE Sodium  dodecyl  sulfate  polyacrylamide  gel  electrophoresis  (SDS‐PAGE)  was carried  out  as  described  (Sambrook  &  Russell,  2001),  routinely  using  8%‐12% polyacrylamide mini‐gels  (PAGs). For  separation of purified complexes  (e.g. TAP, see  section  5.2.5)  and mass  spectrometry  (MS),  precast  4‐12% Bis‐Tris  gradient gels were used. Standard  gels  were  run  at  25  mA  and  150  V,  gradient  gels  according  to  the manufacturer’s manual. Gels  were  routinely  stained  with  Coomassie  Blue  (Sambrook  &  Russell,  2001), gradient  gels with Colloidal Blue,  and  for maximal  sensitivity  silver  staining was used. 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4× Lower Tris              4× Upper Tris 1.5 M Tris                0.5 M Tris  0.4% (w/v) SDS              0.4% (w/v) SDS adjust pH to 8.8              adjust pH to 6.8  store @ RT               store @ RT 
 
10× Tris glycine electrophoresis buffer    20×  MOPS electrophoresis buffer 250 mM Tris              1 M MOPS 1.9 M Glycine              1 M Tris 1% (w/v) SDS              2% (w/v) SDS store @ RT               10 mM EDTA                   store dark @ RT  
Coomassie staining solution        Coomassie destaining solution 0,25% (w/v) Coomassie Brilliant Blue R‐250   30% (v/v) ethanol 0.1% (w/v) Coomassie Brilliant Blue G‐250    10% (v/v) acetic acid 30% (v/v) ethanol            store @ RT 10% (v/v) acetic acid store @ RT  
4× Sample Loading Buffer 0.2 M Tris pH 6.8 40% (v/v) glycerol 8% (w/v) SDS 0.43 M β‐mercaptoethanol few grains Bromophenol Blue store aliquots @ ‐20°C  
5.2.2. Denaturing protein extraction Denaturing  protein  extraction  from  yeast  cells  was  carried  out  essentially  as described  (Knop  et  al.,  1996).  In  brief,  a  small  amount  of  cells  from  plate  was suspended  in 1 ml cold water, 150 µl of pre‐treatment solution were added, and the mixture was  incubated  for 15 min on  ice. After  addition of 150 µl  55%(v/v) trichloroacetic  acid  (TCA)  and  a  further  10  min  incubation  on  ice,  tubes  were centrifuged for 10 min at maximum speed at 4°C in a microfuge. The supernatant was  discarded  completely,  cells  were  resuspended  in  100  µl  buffer  HU  (and neutralized with 1 M Tris  base,  if  indicator  turned yellow)  and  incubated  for 10 min  at  65°C  and  600  rpm  in  a  thermomixer.  After  5  min  centrifugation  at maximum speed, the supernatant was loaded onto a PAG. 




5.2.3.1. Protein transfer To  detect  proteins  on  SDS‐PAGs,  the  stacking  gel was  removed  after  the  course, and  the  gel  was  equilibrated  for  ≥10  min  in  1×  blotting  buffer.  A  sandwich consisting of (from bottom to top) three layers Whatman 3MM paper soaked with 1× blotting buffer, equilibrated PVDF membrane, equilibrated SDS‐PAG, and three layers Whatman  3MM paper  soaked with  1×  blotting  buffer was  assembled  in  a semidry blotting device. To equilibrate the PVDF membrane, it was plunged briefly in methanol, incubated 5 min in water and ≥10 min in 1× blotting buffer. Proteins were  transferred  either  at  1.0  mA/cm2  for  2  h  or  overnight  at  5  V.  Successful transfer was controlled by Ponceau S staining. 
5.2.3.2. Protein detection After blotting, the membrane was blocked for at least 1 h in 1× PBS, 5% (w/v) milk powder. Antibody incubations were done in 1× PBST, 0.5% milk powder. Usually, the membrane was shrink‐wrapped and incubated for 3 h at room temperature or overnight at 4°C with the primary antibody, and 1 h at room temperature with the secondary  antibody,  respectively.  After  each  antibody  incubation,  the membrane was washed three times with 1× PBST, 0.5% milk powder. Signals  were  detected  using  a  chemiluminescence  kit  and  either  films  or  a fluorescent image reader.  




5.2.4.1. Preparation of total RNA from yeast To  collect UV profiles of  ribosomal RNA,  total RNA was  isolated  from yeast  cells under low‐salt conditions as described (Baßler et al., 2001). An overnight culture of the respective yeast strain was diluted and grown in full medium to OD600≈0.5. 50 ml of  the  culture were  transferred  to a  tube,  cycloheximide  (CHX, 10 mg/ml) was added to a final concentration of 0.1 mg/ml, and the tube was incubated for 10 min at 30°C in a water bath. Cells were centrifuged, suspended in 500 µl polysome buffer  supplemented  with  0.1  mg/ml  CHX,  1  mM  DTT,  and  5  U  Superase⋅In, transferred  to  a  1.5  ml  tube  containing  250  µl  small  glass  beads,  and  lysed  by incubating  5  min  on  a  vibrax  (2000  rpm,  4°C).  After  centrifugation  (5  min, maximum speed, 4°C)  in a microfuge,  the clear  supernatant was  transferred  to a new  tube,  RNA  concentration was measured,  and 250–500 µg were  loaded  onto linear sucrose gradients. 
10×  polysome buffer  200 mM HEPES/KOH pH 7.5 750 mM KCl 25 mM MgCl2 10 mM EDTA pH 8.0 adjust pH to 7.5 filter sterilize  
5.2.4.2. Preparation of gradients Linear  7–47%  (w/v)  sucrose  gradients  were  prepared  in  SW40  tubes  with  a Gradient  Master™  gradient  making  station  (BioComp).  Tubes  were  filled  to  a defined mark with light (7%) sucrose solution, then heavy (47%) sucrose solution was added at the bottom of the tube using a syringe. 




5.2.5. Tandem affinity purification  Tandem  affinity  purification  (TAP)  was  carried  out  after  tagging  the  respective ORF with the TAP‐tag at the N‐ or C‐terminus (see section 5.4.3) according to the original protocol (Puig et al., 2001; Rigaut et al., 1999), with some modifications.  
5.2.5.1. Yeast culture Cells were  grown  in 2  l  YPD  to  late  logarithmic phase  (OD600≈3.5),  harvested by centrifugation,  washed  once  with  water  and  frozen  in  50  ml  tubes  in  liquid nitrogen for storage at ‐80°C.   
5.2.5.2. Cell lysis Pellets  were  thawed  on  ice,  and  one  pellet  volume  of  lysis  buffer  (LB), supplemented  with  protease  inhibitors,  was  added.  After  addition  of  two  pellet volumes of small glass beads, cells were lysed using a bead beater (3× 4 min, 510 rpm). Glass beads were removed by filtering, and the cell lysate was pre‐cleared by centrifugation  at  3000  g  and  4°C  for  10  min,  transferred  to  SW32  tubes  and centrifuged for 1 h at 100,000 g (27000 rpm, SW32 swing out rotor). If the protein of interest pelleted under these conditions, centrifugation was done at 60,000 g or 20,000 g,  respectively. Following centrifugation,  the  fatty  top  layer was  removed with a water jet pump. The clear supernatant was transferred to a 50 ml tube, and frozen in liquid nitrogen after addition of glycerol to 5% (v/v).    




10×  TAP lysis buffer (LB)          Elution buffer 1 M NaCl                10 mM Tris/HCl pH 8.0 0.5 M Tris                5 mM EGTA pH 8.0  15 mM MgCl2              prepare freshly 1.5% (v/v) IGEPAL CA‐630 store @ 4°C 
5.2.6. Preparation of glass beads for cell lysis Glass  beads  with  a  diameter  of  0.4  to  0.6  mm  were  plunged  into  a  5  l  flask containing 1 l 0.1 M hydrochloric acid and shaken for 30 min. After several washes with water  to neutralize  the pH, beads were washed  for 30 min with 70% (v/v) ethanol. Beads were then briefly washed with 95% ethanol, dried completely, and autoclaved in bottles.   
5.3. Working with Escherichia coli 
5.3.1. Transformation of chemical competent Escherichia coli TOP10 The  basic  principles  of  this  widely  used  method  are  described  in  Sambrook  & Russell, 2001. 
5.3.1.1. Preparation of competent cells Chemical  competent  E.  coli  TOP10  cells  were  prepared  as  described  previously (Pope & Kent, 1996). In brief, 100 ml LB medium were inoculated with 1 ml of an overnight culture of E. coli TOP10; this culture was grown with vigorous aeration at 130 rpm and 37°C for about 3 h, until the OD600 reached a value between 0.7 and 0.8. Then, the culture was chilled on ice for 15 min before being centrifuged for 15 min at 5000 rpm and 4°C  in a GS3 rotor. Centrifugation was repeated  in a SS‐34 rotor after resuspension of the pellet in 50 ml ice‐cold, sterile 0.1 M CaCl2 and 30 min incubation on ice. The washed pellet was resuspended in 5 ml cold, sterile 0.1 M CaCl2/10% (v/v) glycerol, and 50–100 μl aliquots were stored at –80°C.  
5.3.1.2. Transformation of competent cells Routinely,  one  aliquot  of  chemical  competent E.  coli  cells was  added  to 1 µl  of  a diluted plasmid preparation or 10 µl ligation sample in a 1.5 ml tube. The mixture was  incubated  for  ≥5  min  on  ice,  plated  onto  selection  plates  and  incubated overnight at 37°C (Pope & Kent, 1996). 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5.3.2. Isolation of plasmids from E. coli To isolate plasmids from Escherichia coli liquid cultures, commercial Miniprep Kits were used,  following the manual provided by the manufacturer. The  final elution was reduced to 30 μl. 
5.3.3. Overexpression and purification of His6‐tagged proteins Overnight  cultures of E.  coli  carrying an  inducible plasmid were diluted 1:100  in the  respective  selection medium  and  incubated  at  37°C  and  140  rpm  until  they reached  an  OD600≈0.6.  Then,  isopropyl‐β‐D‐1‐thiogalactopyranoside  (IPTG)  was added  to  a  final  concentration  of  1 mM,  and  cultures were  further  incubated  at 37°C, 140 rpm for 3 hours. Cells were harvested by centrifugation, resuspended in lysis buffer and stored at ‐20°C until needed after shock‐freezing in liquid nitrogen. Cells lysed by sonication, centrifuged,  and  the  supernatant  was  applied  to  a  column  containing  Ni‐NTA agarose pre‐equilibrated with respective purification buffer (PB). The column was closed and incubated for one hour at 4°C. Subsequently, excess liquid was allowed to  drop  out  by  gravity  flow.  The  resin  was  washed  with  5  ml  PB,  1  ml  PB supplemented with 1 M NaCl, 1 ml PB supplemented with 10 mM imidazole. His‐tagged proteins were eluted with 800 µl PB, 300 mM imidazole. 
(example) Lysis buffer      (example) Purification buffer (PB) 50 mM Tris/HCl pH 7.5      50 mM Tris/HCl pH 7.5 500 mM NaCl          150 mM NaCl 2 mM β‐mercaptoethanol      2 mM β‐mercaptoethanol 1× Protease Inhibitor Cocktail 
5.3.4. in vivo RNA chaperone assay To  test  a  possible  RNA  chaperone  activity  of  Loc1,  I  tried  to  establish  an  assay using a ribozyme folding trap as described (Prenninger et al., 2006). 
5.3.4.1. Preparation of E. coli cultures 2 ml TBYEAmp/Cla were inoculated with a single colony of a strain transformed with the respective plasmids. After overnight  incubation at 37°C with shaking, 100 ml TBYEAmp/Cla  were  inoculated with  500 µl  of  this  culture,  protein  expression was induced by adding IPTG to a final concentration of 1 mM, and cells were grown to an OD600 of approximately 0.5. Cultures were harvested by centrifugation (5 min, 2300 g,  4°C)  and  the pellet was  resuspended  in 1 ml TM buffer. The  suspension was transferred to 1.5 ml tubes, spun down, and the pellet was stored at ‐80°C. 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5.3.4.2. Preparation of RNA Pellets  were  suspended  on  ice  in  freshly  prepared  solution  A,  and  cells  were disrupted  by  three  freeze‐thaw  cycles  (freeze:  liquid  nitrogen;  thaw:  30°C water bath).  Subsequently,  20  µl  fresh  solution  B  were  added  and  the  mixture  was incubate for 45‐60 min on ice. After addition of 20 µl solution C and 5 min at room temperature,  200 µl  phenol were  added,  and  highly  pure  RNA was  extracted  as described in section 5.1.6.  
TM buffer           Solution B 10 mM Tris/HCl pH 7.0      4 µl 1 M magnesium acetate 10 mM MgCl2          3.5 µl RQ1 DNase               0.1 µl RNasin 
Solution A           12.4 µl DEPC‐treated water 150 µl TE (10/1) 1.5 µl 1 M DTT          Solution C 0.75 µl RNasin          0.1 M acetic acid 4 µl 10 mg/ml lysozyme      5% (w/v) SDS 0.75 µl DEPC‐treated water  
5.3.4.3. Poisoned primer assay 1 µl 4.5×  hybridization buffer and 1 µl  (5 pmol) end‐labeled NBS‐2 primer were added to 10 µg total RNA in a volume of 2.5 µl. The mixture was heated to 95°C for 1  minute,  then  slowly  cooled  down  to  42°C  in  a  PCR  block  (11s/°C).  Following addition  of  2.3 µl  extension mix,  samples  were  incubated  at  42°C  for  one  hour. Then,  extension  was  stopped  by  adding  7  µl  2×  stop  solution  and  60  µl  100% ethanol, and nucleic acids were precipitated at ‐20°C. After centrifugation (20 min, 16000 rpm, 4°C), pellets were resuspended in 5 µl loading dye and loaded onto a 12% TBE/7 M Urea PAG, which was run at 35 mA and 50W until the bromophenol blue band reached the bottom. Bands were visualized with a Typhoon reader. 
Hybridization buffer       10×  Extension buffer 225 mM HEPES/KOH pH 7      500 mM Tris/HCl pH 8.0 450 mM KCl          50 mM MgCl2               50 mM DTT 
Extension mix 0.67 µl 10× extension buffer    Poisoned dNTP mix 0.33 µl poisoned dNTP mix      3 µl each of 10 mM dATP, dCTP, dGTP, dTTP 0.3 µl AMV reverse transcriptase    25 µl 5 mM ddTTP 1 µl sterile water 
              TBE loading dye 




5.4.1. Dot test  Dot tests are widely used to assay growth of yeast clones on e.g. different selective media  or  different  temperatures  (in  the  case  of  temperature  sensitive mutants). The test was carried out as follows. Cells were suspended in 1 ml sterile medium and OD600 was  adjusted  to  0.2.  From  this  suspension,  a  1:10  dilution  series was prepared with medium. 10 μl of each dilution were then dropped onto respective selection plates. 
5.4.2. Transformation of plasmids into yeast Transformation of yeast strains with plasmids amplified in E. coli was carried out as described (Chen et al., 1992). In brief, a small amount of cells was scraped off a plate, suspended in 1 ml sterile water, and spun down. The pellet was resuspended in 100 µl one‐step buffer and vortexed vigorously, before 10 µl salmon sperm DNA (2 mg/ml)  supplemented with ≥100 ng of plasmid DNA was added. The mixture was  incubated  for  30  min  at  45°C  (temperature  sensitive  strains  25  min  room temperature,  5  min  37°C).  Then,  1  ml  full  medium  was  added,  cells  were  spun down, resuspended in medium and plated onto respective selection plates. 
One­step buffer 0.2 M lithium acetate 40% (w/v) PEG 4000 0.1 M DTT filter sterilize store aliquots @ ‐20°C 
5.4.3. Gene disruption and epitope‐tagging To disrupt  genes  or  tag  genes  of  interest with  epitopes  at  the  C‐  or N‐terminus, homologous recombination of PCR products was used (Baudin et al., 1993).  
5.4.3.1. Preparation of competent cells The applied protocol  is described  in detail  in Knop et al., 1999.  In brief, 50 ml of medium were inoculated with the respective strain, grown to an OD600 of 0.5 to 0.7 at 30°C,  and harvested by  centrifugation at 2000 g  for 5 min. All  centrifugations were carried out at room temperature. Cells were washed once with 0.5 volumes sterile  water  and  once  with  0.1  volumes  LitSorb.  Subsequently,  the  pellet  was resuspended  in 360 μl LitSorb, and 40 μl of  salmon sperm DNA, which had been denatured  for  10  min  at  100°C  and  rapidly  cooled  down  on  ice  before.  After 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mixing,  50  μl  aliquots  are  stored  at  –80°C  (without  shock‐freezing  in  liquid nitrogen). 
TELit pH 8.0        LitSorb 0.1 M lithium acetate      1 M Sorbitol 10 mM Tris pH 8.0      ad 50 ml TELit pH 8.0 1 mM EDTA pH 8.0      filter sterilize adjust pH to 8.0 (acetic acid)  store @ RT autoclave store @ RT  
5.4.3.2. Transformation  For transformation of plasmid DNA, 10 μl of competent cells were used, whereas 50 μl were used for transformation of PCR products. The DNA was placed in 1.5 ml tubes (2 μl plasmid DNA and 10 μl PCR product, respectively) prior to addition of the thawed competent cells. After thorough mixing, 6 volumes LitPEG were added to  the  samples, which were  then,  after  again mixing  them well,  incubated  for 30 min at room temperature. 1/9 volume DMSO was added before placing the cells for 15 min in a water bath at 42°C (temperature sensitive strains: 5 min at 37°C). Cells were centrifuged at 2000 rpm in a microfuge, resuspended in 100 μl medium, and plated onto selection plates. With this method, it was possible to disrupt genes, tag genes  at  the  C‐terminus  and  at  the  N‐terminus  (under  control  of  heterologous promoters) with  published marker  cassettes  (e.g.  Janke  et  al.,  2004;  Knop  et  al., 1999; Puig et al., 2001; Wach et al., 1997; Wach et al., 1994). For N‐terminal tags under the control of the endogenous promoter, a second step had to be carried out. After  tagging, cells were  transformed with a plasmid expressing cre  recombinase (Güldener et al., 1996), that can use loxP sites in tagging cassettes to loop out the heterologous promoter and selection marker (Gauss et al., 2005; Puig et al., 2001).    
LitPEG 40% (w/v) PEG 3350  ad 50 ml TELit pH 8.0 filter sterilize  store @ 4°C 
5.4.4. Mating of yeast strains To mate two haploid yeast strains, an equal amount of cells of either strain  from overnight  cultures  was  transferred  to  a  1.5  ml  tube  containing  1 ml  YPD.  After mixing  and  several  hours  incubation  at  30°C  without  shaking,  cells  were  spun down, washed with water, and spread onto plates selecting for diploids. 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5.4.5. Sporulation and tetrad dissection To  sporulate  a  diploid  strain,  a  single  colony  from  a  fresh  plate was  transferred directly onto a sporulation plate (see section 4.5.2). For strains that are difficult to sporulate  (e.g. BY background), a  colony was streaked out onto a presporulation plate, which was incubated overnight at 30°C. Subsequently, one inoculation loop of  cells  was  streaked  out  onto  a  sporulation  plate  or  used  to  inoculate  2  ml  of sporulation medium. Sporulation was monitored with a light microscope.  For dissection of tetrads, a small amount of sporulated cells was suspended in 100 
µl  sterile  water.  10  µl  of  5 mg/ml  Zymolyase  20T  solution  in  1 M  sorbitol  was added, and after 5 min incubation at 30°C (water bath) 5 µl of the suspension were carefully dropped on the top left side of a rich medium plate. The drop was allowed to  run  down  the  plate  and  dry,  and  tetrads  were  dissected  using  a  tetrad microscope.  
5.4.6. in vivo pulse labeling Pulse labeling of RNA was carried out as described (Ferreira‐Cerca et al., 2005). In brief, 3 ml of  a  logarithmic yeast  culture were pelleted and  resuspended  in 1 ml prewarmed YPD  containing  20 µCi  5´,  6´‐[3H]  ‐uracil  (Amersham)  and  incubated for 15 min at 30°C. Cultures were rapidly cooled down in ice‐water, pelleted, and RNA was  extracted  by  three  rounds  phenol‐chloroform  extraction  (phenol  only, phenol/chloroform/isoamylalcohol  25:24:1,  and  chloroform  only).  After  ≥  1  h ethanol precipitation RNA was dissolved  in 50% deionized  formamide with dyes (bromophenol  blue  and  xylene  cyanol  FF). Quality  and  amount  of  the RNA were checked  on  a  1%  TAE  agarose  gel,  incorporated  radioactivity  by  scintillation counting,  then  equal  amounts  of  radioactivity  were  loaded  onto  a  denaturing agarose gel (section 5.1.9.1). Northern Blot was performed as described above, and signals were visualized using a PhosphoImager Screen.  
5.4.7. Time course for combined Western/Northern Blot In order to  follow ASH1 expression on RNA and protein  level, a  time course with galactose‐inducible  strains  and  subsequent  Northern  and  Western  blot  analysis was performed. 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Strains were grown overnight  in  raffinose‐containing medium, diluted  to 100 ml OD600=0.3  and  grown  to  OD600=0.8‐1.0  at  30°C.  Before  ASH1  expression  was induced  by  adding  20%  (w/v)  galactose  to  a  final  concentration  of  4%,  2  50 ml tubes per  strain and  time point were  filled with 20 ml  ice and chilled on  ice. An equal number of 2 ml safe‐lock tubes were chilled on  ice as well. For each strain and  time  point,  two  times  20  OD600  were  harvested  in  the  ice‐containing  50 ml tubes (3 min, 3600 rpm, 4°C). Supernatant and residual ice was discarded, pellets were resuspended in 1 ml ice‐cold water, transferred to the 2 ml tubes, spun down, snap‐frozen in liquid nitrogen, and stored at ‐80°C.  To  extract  proteins  for  Western  blotting,  pellets  were  suspended  in  400  µl breaking buffer,  and  the  cells were  lysed  twice  for 4 minutes on a vibrax with 2 minutes pause on  ice after addition of 200 µl glass beads. Piercing the bottom of the tubes with a hot 25G needle and centrifuging them in 15 ml tubes removed cell debris.  The  clear  lysate  was  transferred  to  1.5  ml  tubes  and  centrifuged  for  15 minutes  at  maximum  speed  in  a  microfuge  at  4°C.  Protein  concentration  was determined photometrically, and 1 OD280 was loaded onto a SDS‐PAG. Transfer and antibody incubation were performed as described above (section 5.2.3). Extraction of RNA and Northern blotting was performed as described  in sections 5.1.7 and 5.1.9, respectively. 
Breaking buffer 50 mM Tris/HCl pH 7.5 1 mM EDTA pH 8.0 20 mM DTT 1× Protease Inhibitor Cocktail 





5.5.1.1. GFP Yeast  cells  from  a  plate  (of  a  strain  with  a  GFP‐tagged  protein)  were  grown overnight in liquid medium, diluted to OD600=0.2 and grown to OD600≈0.8. 1 ml of the culture was transferred to a 1.5 ml tube, centrifuged, and resuspended in 100 – 200 µl  minimal medium  to  reduce  autofluorescence.  To  immobilize  cells  on  the slide,  agarose  (approx.  2%  (w/v)) was  dissolved  in minimal medium by  heating and dropped onto 3‐well‐slides which were immediately covered with a plain slide to distribute the agarose evenly as a slim layer over the wells. After removal of the plain slide, 5 µl of the concentrated cell suspension were dropped onto the agarose in the wells, covered with a cover slip, and analyzed under the microscope (filter: GFP BP or FITC).  
5.5.1.2. Calcofluor White The protocol for Calcofluor White staining was adapted from a published one (Ni & Snyder, 2001). In brief, a diluted overnight culture was grown to OD600≈4.0. 1 ml of the culture was transferred to a 1.5 ml tube, centrifuged, washed once with 1× PBS, and resuspended in 1 ml 1× PBS containing 2 µg/ml Calcofluor White. After a 10‐minute  incubation  at  room  temperature,  cells were washed  three  times with  1× PBS,  resuspended  in  100  –  200 µl  1×  PBS,  and  5 µl were  spotted  onto  agarose‐coated 3‐well‐slides as described above. Analysis was carried out using  the DAPI filter of the microscope.  
5.5.2. Indirect immunofluorescence 
5.5.2.1. Preparation of slides 0.02% (w/v) poly‐L‐lysine was used  to coat multi‐well  slides. After dropping  the solution onto each well, slides were incubated at room temperature for 5 min and washed three times with deionized water. 
5.5.2.2. Preparation of cells  Cells of respective strains were grown overnight in appropriate selective medium at the appropriate temperature, diluted to OD600≈0.2, and further grown for about two  generations  (OD600=0.7  –  1.0).  37%  Formaldehyde  was  added  to  a  final concentration  of  3.7%(v/v),  and  after  1  h  fixation  cells  were  harvested  and resuspended in 1 ml spheroplasting premix. After transfer of the suspension to 1.5 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ml  tubes,  cells  were  washed  twice  with  1  ml  spheroplasting  premix  and  then carefully  resuspended  in 500 µl  spheroplasting  solution.  Cells were  incubated  at 30°C  in  a  water  bath  for  15  –  60  min,  centrifuged  for  3  min  at  3000  rpm  in  a microfuge,  washed  once  with  1  ml  spheroplasting  premix,  and  resuspended carefully  in  100  –  300  µl  spheroplasting  premix.  Aliquots  were  snap‐frozen  in liquid nitrogen and stored at –80°C. 
Spheroplasting premix    Spheroplasting solution 1.2 M Sorbitol        0.1 mg lyophylized Zymolyase 100T  0.1 M PKi pH 7.5        1 ml spheroplasting premix  0.5 mM MgCl2        28 mM β‐mercaptoethanol autoclave store @ RT 
 
5.5.2.3. Immunofluorescence  Immunofluorescence was carried out essentially as described (Gorsch et al., 1995). 5 µl cell suspension was dropped onto each well. After 5 min incubation at room temperature,  wells  were  blocked  with  blocking  solution  before  applying  the primary antibody (30 µl per well, diluted in blocking solution) and incubating the slide in a humid chamber for 2 h at room temperature. The slide was washed three times  with  1×  TBS,  0.1%  BSA,  0.1%  (w/v)  NP‐40,  the  fluorescent  secondary antibody  (30 µl  per well,  diluted  in  blocking  solution) was  applied  and  the  slide was incubated 2 h in a humid chamber in the dark. After three times washing the slide  with  1×  TBS,  0.1%  BSA,  0.1%  NP‐40,  nuclei  were  stained  by  15  min incubation  at  room  temperature  with  10  µl  DAPI  solution  per  well.  DAPI  was aspirated  off,  1 µl mounting  solution was  pipetted  onto  each well,  and  the  slide was covered with a cover slip and sealed with nail polish. 
Blocking solution      Mounting solution 1× TBS          80% (v/v) glycerol 0.1% (w/v) BSA        1× PBS  
Table 7   Primary antibodies used in indirect immunofluorescence. primary antibody  dilution in blocking solution mouse α‐HA (clone 16B12)   1:1000 mouse α‐myc (clone 9E10)  1:1000 mouse α‐fibrillarin (clone 28F2)  1:2000 rabbit α‐She2 (323/4, E12, #7)  1:1000 rat α‐HA (clone 3F10)  1:200 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Table 8   Fluorescent secondary antibodies used in indirect immunofluorescence. secondary antibody  dilution in blocking solution Alexa Fluor® 488 goat α‐mouse  1:250 Alexa Fluor® 488 goat α‐rabbit  1:300 Alexa Fluor® 488 goat α‐rat  1:100 Alexa Fluor® 594 rabbit α‐mouse  1:1000  
5.5.3. Fluorescent in situ hybridization 
5.5.3.1. Preparation of Cy3‐labeled ASH1 probes For  fluorescent  in  situ  hybridization  (FISH)  of  ASH1  mRNA,  a  mixture  of  five oligonucleotides directly labeled with Cy3 (see section 4.4.1.1) was used. A stock of the  mixture  was  prepared  with  10  µl  DEPC‐treated  water  and  2  µl  of  each oligonucleotide (Vf=20µl, cf/oligo= 10 µM). 1 µl of the stock mixture was diluted with 79  µl  DEPC‐treated  water,  10  µl  10  mg/ml  tRNA,  and  10  µl  10  mg/ml  herring sperm DNA  (Vf=100µl,  cf/oligo=  100  nM).  This  solution was  divided  into  10  10 µl aliquots, which were dried in a speed vac.   
5.5.3.2. Preparation of DIG‐labeled probes 
IST2  mRNA  and  WSC2  mRNA  were  detected  with  digoxigenin  (DIG)‐labeled oligonucleotides.  For  each  mRNA,  four  DNA  fragments  (each  approx.  250  bp) spanning  the  complete  ORF  were  amplified  by  PCR  (see  section  5.1.5),  purified with a PCR purification kit, phenol‐chloroform‐extracted and precipitated in 100% ethanol for ≥2 h. Subsequent labeling with DIG‐UTP was carried out with roughly 1 





freshly  prepared  Oxalyticase  solution,  incubated  for  10  min  at  30°C  in  a  water bath, washed once in 1× buffer B and finally resuspended in 100 – 200 µl buffer B on  ice. 5  to 10 µl  of  the  spheroplast  suspension was  spotted per well on poly‐L‐lysine coated slides (see section 5.5.2.1). Following a 30 min incubation on ice, the suspension was  diluted with  one  large  drop  of  1×  buffer  B,  aspirated  off with  a water jet pump, and plunged into a jar containing 70% ethanol pre‐cooled to –20°C for storage at –20°C. 
1×  Buffer B        Oxalyticase solution 1.2 M Sorbitol        0.1 mg lyophylized oxalyticase 0.1 M PKi pH 7.5       720 µl buffer B autoclave          100 µl 200 mM Ribonucleoside Vanadyl complex store @ RT         3.5 µl 5 mM AEBSF              3 µl RNasin             2 µl 1 M DTT             ad 1 ml DEPC‐treated water  
5.5.3.4. in situ hybridization with Cy3‐labeled probes For  hybridization,  two  probe  aliquots  per  slide  are  needed.  The  protocol  was adapted from Long et al., 1997. 15 µl hybridization solution 1 were added to each tube at  room  temperature,  and after 3 min  incubation at 80°C and 300  rpm and addition of 15 µl hybridization solution 2 on ice, the tubes were spun for 15 min at maximum speed and 4°C. Cells were rehydrated 5 min in 2× SSC and 5 min in 2× SSC, 40%  formamide, before 5 µl  probe were  transferred  to  each well. The  slide was  covered with  a  cover  slip  and  incubated  overnight  at  37°C  in  a  dark  humid chamber.  Slides  were  washed  subsequently  twice  for  15 min  in  prewarmed  2×  SSC,  40% formamide at 37°C, in 2× SSC, 0.1% Triton X‐100 at room temperature, and in 1× SSC, also at room temperature. DAPI‐staining of nuclei and mounting was carried out as described above (section 5.5.2.3). 
Hybridization solution 1      Hybridization solution 2 49.3 µl formamide        12.3 µl 20 mg/ml BSA 0.63 µl 1 M PNai          36.2 µl DEPC‐treated water 11.7 µl DEPC‐treated water      12.3 µl 20× SSC               0.75 µl RNasin  




≈80  rpm).  Incubation  with  the  primary  antibody  (mouse α‐DIG,  dilution  1:250) was done  for 2 h. All  antibody  incubations were done  at  room  temperature  in  a dark humid chamber, and antibodies were diluted in blocking solution. After three 1  min  washes  with  1×  PBS,  0.1%  BSA,  the  slides  were  incubated  with  the secondary antibody (Alexa Fluor® 488 rabbit α‐mouse IgG, dilution 1:2000) for 1 h.  The  tertiary  antibody  (Alexa  Fluor®  488  goat α‐rabbit  IgG,  dilution  1:10000) was applied  for 1 h  after  three 1 min washes with 1×  PBS, 0.1% BSA. Following three  final  washes,  DAPI  staining  and  mounting  were  carried  out  as  described above.  
HybMix            Blocking solution 50%(v/v) formamide        1× PBS 5× SSC            10% fetal calf serum (FCS) 5 mM (0.4 ml 0.5 M) EDTA pH 8.0   0.1% (v/v) Triton X‐100 0.1% (v/v) Tween‐20        ad 100 ml DEPC‐treated water 1× Denhardt´s 0.1% (0.4 ml 10%) CHAPS 0.1 mg/ml herring sperm DNA 0.1 mg/ml heparin ad 40 ml DEPC‐treated water  
50×  Denhardt´s reagent 1% (w/v) BSA 1% (w/v) Ficoll 1% (w/v) polyvinylpyrrolidine (PVP) 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Übersetzungen der fremdsprachigen Zitate: Summary:   Man muss erkennen, dass eine kurze wie eine lange Erklärung auf dasselbe abzielen. Results:  (...) ich könnte kein größeres Geschenk machen, als die Gelegenheit zu geben, in kürzester Zeit  in all das Einblick zu nehmen, was  ich  in  so vielen  Jahren und unter so vielen Unannehmlichkeiten erfahren und verstanden habe.  Discussion:    Niemals sagt die Natur das eine, die Weisheit das andere. Methods:      So kocht man das: (...) Acknowledgements:  Wer  eine Wohltat  erwiesen  hat,  soll  schweigen.  Der  soll  (davon)  erzählen, der sie empfangen hat.  
